{"items": "97", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - C3.ai  ( NYSE:AI ) , Asset Entities  ( NASDAQ:ASST ) ", "url": "https://www.benzinga.com/24/12/42408189/why-c3-ai-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket", "time_published": "20241210T110529", "authors": ["Avi Kapoor"], "summary": "Shares of C3.ai, Inc. AI rose sharply in today's pre-market trading session after the company reported better-than-expected second-quarter financial results. C3.ai reported quarterly losses of six cents per share, which beat the analyst consensus estimate for losses of 16 cents.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/10/C3-ai-signage.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.897321"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.070299, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "YEXT", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.251212", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CPIX", "relevance_score": "0.162802", "ticker_sentiment_score": "0.145645", "ticker_sentiment_label": "Neutral"}, {"ticker": "GELS", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.159052", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MNTS", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.332846", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PCSA", "relevance_score": "0.162802", "ticker_sentiment_score": "0.209914", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RADX", "relevance_score": "0.162802", "ticker_sentiment_score": "0.024271", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.162802", "ticker_sentiment_score": "0.209914", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VEEE", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.016187", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRM", "relevance_score": "0.162802", "ticker_sentiment_score": "0.062562", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASST", "relevance_score": "0.162802", "ticker_sentiment_score": "0.148024", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.162802", "ticker_sentiment_score": "0.219259", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TNMG", "relevance_score": "0.162802", "ticker_sentiment_score": "0.326325", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LPTH", "relevance_score": "0.162802", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUIZ", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.205138", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NBTX", "relevance_score": "0.242084", "ticker_sentiment_score": "-0.267384", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DUO", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.15369", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday - Constellation Brands  ( NYSE:STZ ) ", "url": "https://www.benzinga.com/news/earnings/24/10/41158294/constellation-brands-levi-strauss-and-3-stocks-to-watch-heading-into-thursday", "time_published": "20241003T071046", "authors": ["Avi Kapoor"], "summary": "With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Constellation Brands, Inc. STZ to report quarterly earnings at $4.08 per share on revenue of $2.90 billion before the opening bell, according ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/03/Constellation-Brands.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.947132"}], "overall_sentiment_score": 0.285921, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.379051", "ticker_sentiment_score": "0.554893", "ticker_sentiment_label": "Bullish"}, {"ticker": "STZ", "relevance_score": "0.258351", "ticker_sentiment_score": "0.158519", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Nasdaq Down 1%; JetBlue Airways Shares Spike Higher - JetBlue Airways  ( NASDAQ:JBLU ) ", "url": "https://www.benzinga.com/news/earnings/24/07/40047993/nasdaq-down-1-jetblue-airways-shares-spike-higher", "time_published": "20240730T183101", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining more than 200 points on Tuesday. The Dow traded up 0.53% to 40,755.30 while the NASDAQ dipped 1.02% to 17,190.93. The S&P 500 also fell, dropping, 0.40% to 5,441.42. Energy shares jumped by 1.3% on Tuesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/30/jetblue-shutter.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.143493, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EKSO", "relevance_score": "0.136113", "ticker_sentiment_score": "0.145591", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.136113", "ticker_sentiment_score": "-0.348043", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JBLU", "relevance_score": "0.136113", "ticker_sentiment_score": "0.428154", "ticker_sentiment_label": "Bullish"}, {"ticker": "CEG", "relevance_score": "0.068306", "ticker_sentiment_score": "0.185163", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCSA", "relevance_score": "0.136113", "ticker_sentiment_score": "0.020588", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNN", "relevance_score": "0.202932", "ticker_sentiment_score": "0.316658", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:EUR", "relevance_score": "0.068306", "ticker_sentiment_score": "-0.048112", "ticker_sentiment_label": "Neutral"}]}, {"title": "Crude Oil Down 1%; Procter & Gamble Shares Fall After Q4 Results - Procter & Gamble  ( NYSE:PG ) ", "url": "https://www.benzinga.com/news/earnings/24/07/40044855/crude-oil-down-1-procter-gamble-shares-fall-after-q4-results", "time_published": "20240730T161627", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 1% on Tuesday. The Dow traded up 0.20% to 40,622.69 while the NASDAQ dipped 1.05% to 17,188.10. The S&P 500 also fell, dropping, 0.51% to 5,435.63. Financials shares jumped by 1.3% on Tuesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/30/Crude-oil-4-logo.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.744043"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.103359, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EKSO", "relevance_score": "0.121959", "ticker_sentiment_score": "0.138146", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBLU", "relevance_score": "0.121959", "ticker_sentiment_score": "0.40855", "ticker_sentiment_label": "Bullish"}, {"ticker": "CEG", "relevance_score": "0.061159", "ticker_sentiment_score": "0.183348", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCSA", "relevance_score": "0.121959", "ticker_sentiment_score": "0.019413", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNN", "relevance_score": "0.182047", "ticker_sentiment_score": "0.293583", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PG", "relevance_score": "0.121959", "ticker_sentiment_score": "-0.100289", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.121959", "ticker_sentiment_score": "-0.331282", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FOREX:EUR", "relevance_score": "0.061159", "ticker_sentiment_score": "-0.048", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Jumps 200 Points; Pfizer Earnings Top Views - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/news/earnings/24/07/40039782/dow-jumps-200-points-pfizer-earnings-top-views", "time_published": "20240730T141254", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.50% to 40,742.44 while the NASDAQ slipped 0.01% to 17,370.07. The S&P 500 also rose, gaining, 0.22% to 5,475.80.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/30/wall-street-chart-shutter2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.178171, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CEG", "relevance_score": "0.058759", "ticker_sentiment_score": "0.182905", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCSA", "relevance_score": "0.1172", "ticker_sentiment_score": "0.019044", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNN", "relevance_score": "0.175009", "ticker_sentiment_score": "0.285897", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NIPG", "relevance_score": "0.175009", "ticker_sentiment_score": "0.105088", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNSP", "relevance_score": "0.1172", "ticker_sentiment_score": "0.142924", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATPC", "relevance_score": "0.175009", "ticker_sentiment_score": "0.591304", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.287537", "ticker_sentiment_score": "0.045088", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.047982", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer", "url": "https://www.globenewswire.com/news-release/2024/06/11/2896777/0/en/Processa-Pharmaceuticals-Announces-Positive-Efficacy-Results-from-Preliminary-Evaluation-of-Phase-1b-Dose-escalating-Trial-with-NGC-Cap-in-Gastrointestinal-Cancer.html", "time_published": "20240611T122000", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "Eight of 12 evaluable patients ( 66.7% ) had progression-free survival ( PFS ) ranging from 5 to 11 months ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.120087, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "OPTGF", "relevance_score": "0.031529", "ticker_sentiment_score": "0.129733", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.09439", "ticker_sentiment_score": "0.04277", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Alphabet  ( NASDAQ:GOOGL ) ", "url": "https://www.benzinga.com/news/24/04/38458188/why-alphabet-shares-are-trading-higher-by-12-here-are-20-stocks-moving-premarket", "time_published": "20240426T121832", "authors": ["Avi Kapoor"], "summary": "Shares of Alphabet Inc. GOOGL GOOG rose sharply in today's pre-market trading the company posted upbeat results for its first quarter. Google parent Alphabet said its first-quarter revenue increased 15% year-over-year to $80.539 billion, beating the consensus estimate of $78.594 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/26/Google-Parent-Alphabet.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.997874"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.195338, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VINC", "relevance_score": "0.132733", "ticker_sentiment_score": "-0.035974", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.197951", "ticker_sentiment_score": "0.125537", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.132733", "ticker_sentiment_score": "0.291799", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ELWS", "relevance_score": "0.132733", "ticker_sentiment_score": "0.198737", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCSA", "relevance_score": "0.197951", "ticker_sentiment_score": "-0.033421", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMD", "relevance_score": "0.132733", "ticker_sentiment_score": "0.332088", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BYD", "relevance_score": "0.132733", "ticker_sentiment_score": "-0.045209", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAP", "relevance_score": "0.132733", "ticker_sentiment_score": "0.362713", "ticker_sentiment_label": "Bullish"}, {"ticker": "TVGN", "relevance_score": "0.132733", "ticker_sentiment_score": "0.206403", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HTZ", "relevance_score": "0.132733", "ticker_sentiment_score": "-0.056085", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIVF", "relevance_score": "0.132733", "ticker_sentiment_score": "0.186695", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "INTC", "relevance_score": "0.132733", "ticker_sentiment_score": "0.054284", "ticker_sentiment_label": "Neutral"}, {"ticker": "WORX", "relevance_score": "0.132733", "ticker_sentiment_score": "-0.238178", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FRGT", "relevance_score": "0.132733", "ticker_sentiment_score": "0.210694", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KTRA", "relevance_score": "0.132733", "ticker_sentiment_score": "0.458937", "ticker_sentiment_label": "Bullish"}, {"ticker": "CSSE", "relevance_score": "0.197951", "ticker_sentiment_score": "-0.377607", "ticker_sentiment_label": "Bearish"}, {"ticker": "DXCM", "relevance_score": "0.132733", "ticker_sentiment_score": "-0.050567", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.197951", "ticker_sentiment_score": "-0.192449", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results - ATN International  ( NASDAQ:ATNI ) , Bristol-Myers Squibb  ( NYSE:BMY ) ", "url": "https://www.benzinga.com/news/earnings/24/04/38441305/crude-oil-moves-higher-bristol-myers-squibb-shares-fall-after-q1-results", "time_published": "20240425T183233", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling by around 100 points on Thursday. The Dow traded down 1.20% to 37,998.27 while the NASDAQ fell 0.85% to 15,578.58. The S&P 500 also fell, dropping, 0.70% to 5,035.88. Materials shares rose by 0.7% on Thursday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/25/BristolMeyersSquibb-Courtesyof-02-LVL-Ex_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.012209, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATNI", "relevance_score": "0.121037", "ticker_sentiment_score": "-0.135743", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.060694", "ticker_sentiment_score": "0.101004", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.121037", "ticker_sentiment_score": "0.173238", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JAKK", "relevance_score": "0.121037", "ticker_sentiment_score": "-0.299416", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PI", "relevance_score": "0.121037", "ticker_sentiment_score": "0.389295", "ticker_sentiment_label": "Bullish"}, {"ticker": "ULBI", "relevance_score": "0.121037", "ticker_sentiment_score": "0.40734", "ticker_sentiment_label": "Bullish"}, {"ticker": "BMY", "relevance_score": "0.180685", "ticker_sentiment_score": "-0.033345", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTZ", "relevance_score": "0.121037", "ticker_sentiment_score": "0.145715", "ticker_sentiment_label": "Neutral"}]}, {"title": "S&P 500 Down Over 1%; Merck Increases 2024 Outlook - ATN International  ( NASDAQ:ATNI ) , Hertz Global Holdings  ( NASDAQ:HTZ ) ", "url": "https://www.benzinga.com/news/earnings/24/04/38437240/s-p-500-down-over-1-merck-increases-2024-outlook", "time_published": "20240425T160430", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling by around 250 points on Thursday. The Dow traded down 1.55% to 37,864.79 while the NASDAQ fell 1.60% to 15,460.95. The S&P 500 also fell, dropping, 1.16% to 5,012.94. Energy shares fell by just 0.2% on Thursday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/25/Stock-Market_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.034202, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATNI", "relevance_score": "0.127795", "ticker_sentiment_score": "-0.139477", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.064104", "ticker_sentiment_score": "0.101082", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.127795", "ticker_sentiment_score": "0.177508", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PI", "relevance_score": "0.127795", "ticker_sentiment_score": "0.398084", "ticker_sentiment_label": "Bullish"}, {"ticker": "ULBI", "relevance_score": "0.127795", "ticker_sentiment_score": "0.416416", "ticker_sentiment_label": "Bullish"}, {"ticker": "ORN", "relevance_score": "0.127795", "ticker_sentiment_score": "-0.36234", "ticker_sentiment_label": "Bearish"}, {"ticker": "HTZ", "relevance_score": "0.127795", "ticker_sentiment_score": "0.149318", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Dips Over 500 Points; US GDP Growth Misses Expectations - Barfresh Food Group  ( NASDAQ:BRFH ) , Chicken Soup for the Soul  ( NASDAQ:CSSE ) ", "url": "https://www.benzinga.com/news/earnings/24/04/38432253/dow-dips-over-500-points-us-gdp-growth-misses-expectations", "time_published": "20240425T134704", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded lower this morning, with the Dow Jones index tumbling by more than 500 points on Thursday. Following the market opening Thursday, the Dow traded down 1.42% to 37,915.92 while the NASDAQ fell 2.16% to 15,374.09. The S&P 500 also fell, dropping, 1.37% to 5,002.04.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/25/Frustrated-Stressed-Shocked-Business-Man.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": -0.026783, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.073546", "ticker_sentiment_score": "0.101804", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.146469", "ticker_sentiment_score": "0.190593", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HRYU", "relevance_score": "0.218161", "ticker_sentiment_score": "-0.063658", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUIZ", "relevance_score": "0.146469", "ticker_sentiment_score": "0.034563", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGBX", "relevance_score": "0.218161", "ticker_sentiment_score": "0.214424", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BRFH", "relevance_score": "0.146469", "ticker_sentiment_score": "0.438686", "ticker_sentiment_label": "Bullish"}, {"ticker": "CSSE", "relevance_score": "0.218161", "ticker_sentiment_score": "-0.420088", "ticker_sentiment_label": "Bearish"}]}, {"title": "Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference", "url": "https://www.globenewswire.com/news-release/2024/03/28/2853979/0/en/Processa-Pharmaceuticals-to-Present-at-the-MedInvest-Biotech-and-Pharma-Investor-Conference.html", "time_published": "20240328T121500", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, March 28, 2024 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.202126, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "OPTGF", "relevance_score": "0.076115", "ticker_sentiment_score": "0.140786", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.2256", "ticker_sentiment_score": "-0.017836", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting", "url": "https://www.globenewswire.com/news-release/2024/03/25/2851598/0/en/Processa-Pharmaceuticals-to-Present-Data-at-the-American-Association-for-Cancer-Research-Annual-Meeting.html", "time_published": "20240325T121500", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, March 25, 2024 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.17414, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "OPTGF", "relevance_score": "0.124809", "ticker_sentiment_score": "0.141314", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.186259", "ticker_sentiment_score": "-0.058647", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference", "url": "https://www.globenewswire.com/news-release/2024/02/21/2832738/0/en/Processa-Pharmaceuticals-to-Present-at-the-2024-BIO-CEO-Investor-Conference.html", "time_published": "20240221T131500", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.200076, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "OPTGF", "relevance_score": "0.07913", "ticker_sentiment_score": "0.141687", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.234307", "ticker_sentiment_score": "-0.018354", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference", "url": "https://www.globenewswire.com/news-release/2024/02/14/2829368/0/en/Processa-Pharmaceuticals-to-Present-at-The-Winter-Wrap-Up-MicroCap-Rodeo-Winter-2024-Virtual-Conference.html", "time_published": "20240214T180000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Feb. 14, 2024 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.200269, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.237358", "ticker_sentiment_score": "-0.022321", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying - Abeona Therapeutics  ( NASDAQ:ABEO ) , OPKO Health  ( NASDAQ:OPK ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/02/37009155/processa-pharmaceuticals-and-2-other-penny-stocks-insiders-are-buying", "time_published": "20240208T144104", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/02/08/image21.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.238786, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.560594", "ticker_sentiment_score": "0.399276", "ticker_sentiment_label": "Bullish"}, {"ticker": "ABEO", "relevance_score": "0.560594", "ticker_sentiment_score": "0.270328", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OPK", "relevance_score": "0.560594", "ticker_sentiment_score": "0.37177", "ticker_sentiment_label": "Bullish"}]}, {"title": "Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule", "url": "https://www.globenewswire.com/news-release/2024/02/06/2824321/0/en/Processa-Pharmaceuticals-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Rule.html", "time_published": "20240206T133000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Feb. 06, 2024 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.195144, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.226301", "ticker_sentiment_score": "-0.007142", "ticker_sentiment_label": "Neutral"}]}, {"title": "Expensify And 3 Other Stocks Under $3 Insiders Are Buying - Expensify  ( NASDAQ:EXFY ) , Perspective Therapeutics  ( AMEX:CATX ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/02/36907167/expensify-and-3-other-stocks-under-3-insiders-are-buying", "time_published": "20240202T120911", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/02/02/image44.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.291489, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.398781", "ticker_sentiment_score": "0.351024", "ticker_sentiment_label": "Bullish"}, {"ticker": "EXFY", "relevance_score": "0.398781", "ticker_sentiment_score": "0.297364", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering", "url": "https://www.globenewswire.com/news-release/2024/02/01/2822471/0/en/Processa-Pharmaceuticals-Announces-Closing-of-7-0-Million-Public-Offering.html", "time_published": "20240201T212200", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, Feb. 01, 2024 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Financial Markets", "relevance_score": "0.891286"}], "overall_sentiment_score": 0.135801, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.091335", "ticker_sentiment_score": "0.063751", "ticker_sentiment_label": "Neutral"}]}, {"title": "Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying - Processa Pharma  ( NASDAQ:PCSA ) , PaySign  ( NASDAQ:PAYS ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/24/02/36887261/relmada-therapeutics-and-2-other-penny-stocks-insiders-are-buying", "time_published": "20240201T134254", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed lower by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/02/01/image10.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.275953, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.454714", "ticker_sentiment_score": "0.388829", "ticker_sentiment_label": "Bullish"}, {"ticker": "PAYS", "relevance_score": "0.454714", "ticker_sentiment_score": "0.530545", "ticker_sentiment_label": "Bullish"}, {"ticker": "RLMD", "relevance_score": "0.454714", "ticker_sentiment_score": "0.224233", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results - Colgate-Palmolive  ( NYSE:CL ) , AppFolio  ( NASDAQ:APPF ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36807767/nasdaq-down-over-50-points-colgate-palmolive-posts-upbeat-results", "time_published": "20240126T193218", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling over 50 points on Friday The Dow traded up 0.05% to 38,069.66 while the NASDAQ fell 0.4% to 15,447.78. The S&P 500 also fell, dropping, 0.15% to 4,886.79. Health care shares rose by 0.5% on Friday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/26/colgate-palmolive_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Economy - Fiscal", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.650727"}], "overall_sentiment_score": 0.031368, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRBP", "relevance_score": "0.130217", "ticker_sentiment_score": "0.141193", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVVE", "relevance_score": "0.130217", "ticker_sentiment_score": "0.05256", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.130217", "ticker_sentiment_score": "-0.096264", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHJTF", "relevance_score": "0.065327", "ticker_sentiment_score": "0.120183", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKLF", "relevance_score": "0.130217", "ticker_sentiment_score": "0.116347", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.130217", "ticker_sentiment_score": "0.256094", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BKR", "relevance_score": "0.065327", "ticker_sentiment_score": "0.233683", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CL", "relevance_score": "0.194242", "ticker_sentiment_score": "0.083578", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPF", "relevance_score": "0.130217", "ticker_sentiment_score": "0.399029", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.065327", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Crude Oil Down 1%; American Express Shares Rise After Q4 Results - American Express  ( NYSE:AXP ) , AppFolio  ( NASDAQ:APPF ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36805309/crude-oil-down-1-american-express-shares-rise-after-q4-results", "time_published": "20240126T170026", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Friday. The Dow traded up 0.32% to 38,170.95 while the NASDAQ rose 0.10% to 15,525.24. The S&P 500 also rose, gaining, 0.19% to 4,903.28. Health care shares rose by 0.5% on Friday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/26/crude_oil3_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Economy - Fiscal", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.074541, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRBP", "relevance_score": "0.134214", "ticker_sentiment_score": "0.143338", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.134214", "ticker_sentiment_score": "-0.097731", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHJTF", "relevance_score": "0.067347", "ticker_sentiment_score": "0.120326", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.200134", "ticker_sentiment_score": "0.018479", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKLF", "relevance_score": "0.134214", "ticker_sentiment_score": "0.118118", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.134214", "ticker_sentiment_score": "0.259881", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AXP", "relevance_score": "0.200134", "ticker_sentiment_score": "0.182566", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "APPF", "relevance_score": "0.134214", "ticker_sentiment_score": "0.404487", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.067347", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "What's Going With Processa Pharmaceuticals Stock Today? - Processa Pharma  ( NASDAQ:PCSA ) ", "url": "https://www.benzinga.com/general/biotech/24/01/36804201/whats-going-on-with-anti-cancer-focused-processa-pharmaceuticals-stock-today", "time_published": "20240126T161653", "authors": ["Vandana Singh"], "summary": "Thursday, Processa Pharmaceuticals Inc PCSA shares closed 148.8% higher at $5.10.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/PCSA.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.05226, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.453501", "ticker_sentiment_score": "0.211673", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering - Processa Pharma  ( NASDAQ:PCSA ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36801112/processa-pharmaceuticals-announces-pricing-of-7-0-million-public-offering", "time_published": "20240126T140403", "authors": ["Globe Newswire"], "summary": "HANOVER, Md., Jan. 26, 2024 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.769861"}, {"topic": "Financial Markets", "relevance_score": "0.938793"}], "overall_sentiment_score": 0.14016, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.084572", "ticker_sentiment_score": "0.063678", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering", "url": "https://www.globenewswire.com/news-release/2024/01/26/2817975/0/en/Processa-Pharmaceuticals-Announces-Pricing-of-7-0-Million-Public-Offering.html", "time_published": "20240126T140400", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, Md., Jan. 26, 2024 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/673458bd-e061-4a23-abf5-e95258728734", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.769861"}, {"topic": "Financial Markets", "relevance_score": "0.891286"}], "overall_sentiment_score": 0.149856, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.087503", "ticker_sentiment_score": "0.068502", "ticker_sentiment_label": "Neutral"}]}, {"title": "Intel, Nvidia, AMD, Processa Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today - Intel  ( NASDAQ:INTC ) , Advanced Micro Devices  ( NASDAQ:AMD ) ", "url": "https://www.benzinga.com/markets/equities/24/01/36794916/intel-nvidia-amd-processa-pharmaceuticals-tesla-why-these-5-stocks-are-on-investors-radars-today", "time_published": "20240126T021427", "authors": ["Benzinga Neuro"], "summary": "U.S. stocks ended in the green on Thursday with the Nasdaq rising 0.2% to 15,510.50 and the S&P 500 up 0.5% at 4,894.16. The Dow Jones Industrial average also rose, gaining 0.6% to 38,094.13. These are the top stocks that gained the attention of retail traders and investors throughout the day:", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/Stocks-Photo-by-Phongphan-on-Shutterstoc_4.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.650727"}], "overall_sentiment_score": 0.107572, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.320279", "ticker_sentiment_score": "0.133561", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.109455", "ticker_sentiment_score": "-0.098682", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.109455", "ticker_sentiment_score": "0.05657", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.21686", "ticker_sentiment_score": "0.092103", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq Edges Lower; American Airlines Posts Upbeat Earnings - American Superconductor  ( NASDAQ:AMSC ) , American Airlines Group  ( NASDAQ:AAL ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36789093/nasdaq-edges-lower-american-airlines-posts-upbeat-earnings", "time_published": "20240125T201818", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.25% to 37,900.45 while the NASDAQ fell 0.13% to 15,462.53. The S&P 500 also rose, gaining, 0.19% to 4,877.88. In trading on Thursday, consumer discretionary shares fell by ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/25/image19.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.995921"}], "overall_sentiment_score": 0.07434, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RDHL", "relevance_score": "0.12165", "ticker_sentiment_score": "0.137995", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.12165", "ticker_sentiment_score": "0.393466", "ticker_sentiment_label": "Bullish"}, {"ticker": "PCSA", "relevance_score": "0.12165", "ticker_sentiment_score": "0.24723", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VERA", "relevance_score": "0.12165", "ticker_sentiment_score": "0.131108", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAL", "relevance_score": "0.240489", "ticker_sentiment_score": "0.201793", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HZO", "relevance_score": "0.12165", "ticker_sentiment_score": "0.170164", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "COLB", "relevance_score": "0.12165", "ticker_sentiment_score": "-0.109324", "ticker_sentiment_label": "Neutral"}]}, {"title": "Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results - Intelligent Bio Solutions  ( NASDAQ:INBS ) , Akoustis Technologies  ( NASDAQ:AKTS ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36786638/crude-oil-rises-2-tesla-shares-plunge-after-downbeat-results", "time_published": "20240125T180822", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday. The Dow traded up 0.06% to 37,829.32 while the NASDAQ rose 0.22% to 15,515.62. The S&P 500 also rose, gaining, 0.26% to 4,881.28. Communication services shares rose by 1.5% on ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/25/image48.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.917436"}], "overall_sentiment_score": 0.07884, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RDHL", "relevance_score": "0.119235", "ticker_sentiment_score": "0.136827", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.178021", "ticker_sentiment_score": "0.085762", "ticker_sentiment_label": "Neutral"}, {"ticker": "INBS", "relevance_score": "0.178021", "ticker_sentiment_score": "-0.325987", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PCSA", "relevance_score": "0.119235", "ticker_sentiment_score": "0.245173", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VERA", "relevance_score": "0.119235", "ticker_sentiment_score": "0.129998", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTS", "relevance_score": "0.119235", "ticker_sentiment_score": "0.09818", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.059785", "ticker_sentiment_score": "-0.28619", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LVTX", "relevance_score": "0.119235", "ticker_sentiment_score": "0.249736", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Processa Pharmaceuticals Stock Is Soaring - Processa Pharma  ( NASDAQ:PCSA ) ", "url": "https://www.benzinga.com/news/24/01/36784420/why-processa-pharmaceuticals-stock-is-soaring", "time_published": "20240125T163218", "authors": ["Erica Kollmann"], "summary": "Processa Pharmaceuticals, Inc. PCSA shares are soaring Thursday after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/pills-1173653-1280.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.255358, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.595343", "ticker_sentiment_score": "0.563225", "ticker_sentiment_label": "Bullish"}]}, {"title": "Dow Surges Over 100 Points; US GDP Growth Tops Estimates - Intelligent Bio Solutions  ( NASDAQ:INBS ) , Akoustis Technologies  ( NASDAQ:AKTS ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36783052/dow-surges-over-100-points-us-gdp-growth-tops-estimates", "time_published": "20240125T154228", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.33% to 37,932.33 while the NASDAQ rose 0.37% to 15,538.69. The S&P 500 also rose, gaining, 0.40% to 4,887.88.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/25/image20.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.00242, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RDHL", "relevance_score": "0.156461", "ticker_sentiment_score": "0.157699", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "INBS", "relevance_score": "0.156461", "ticker_sentiment_score": "-0.267162", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PCSA", "relevance_score": "0.156461", "ticker_sentiment_score": "0.281384", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LVTX", "relevance_score": "0.156461", "ticker_sentiment_score": "0.250309", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ONCO", "relevance_score": "0.156461", "ticker_sentiment_score": "0.0528", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTS", "relevance_score": "0.156461", "ticker_sentiment_score": "0.118454", "ticker_sentiment_label": "Neutral"}]}, {"title": "US Stocks Higher; Nasdaq Jumps 100 Points - Nuvve Holding  ( NASDAQ:NVVE ) , Fisker  ( NYSE:FSR ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36717533/us-stocks-higher-nasdaq-jumps-100-points", "time_published": "20240122T151514", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded up 0.55% to 38,073.10 while the NASDAQ rose 0.71% to 15,420.00. The S&P 500 also rose, gaining, 0.49% to 4,863.49.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/22/image_5.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.075149, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VIRI", "relevance_score": "0.261117", "ticker_sentiment_score": "0.01611", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVVE", "relevance_score": "0.261117", "ticker_sentiment_score": "-0.38132", "ticker_sentiment_label": "Bearish"}, {"ticker": "FSR", "relevance_score": "0.261117", "ticker_sentiment_score": "0.401923", "ticker_sentiment_label": "Bullish"}, {"ticker": "PCSA", "relevance_score": "0.261117", "ticker_sentiment_score": "0.117635", "ticker_sentiment_label": "Neutral"}, {"ticker": "BACHY", "relevance_score": "0.088472", "ticker_sentiment_score": "-0.025255", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.261117", "ticker_sentiment_score": "0.329066", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SGMT", "relevance_score": "0.175859", "ticker_sentiment_score": "0.17033", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "S&P 500 Gains 1%; State Street Reports Upbeat Earnings - C3is  ( NASDAQ:CISS ) , Anitra  ( AMEX:AZTR ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36700365/s-p-500-gains-1-state-street-reports-upbeat-earnings", "time_published": "20240119T191704", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.95% to 37,824.10 while the NASDAQ rose 1.39% to 15,264.30. The S&P 500 also rose, gaining, 1.06% to 4,831.75. Information technology shares rose by 1.6% on ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/19/image50.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.495866"}], "overall_sentiment_score": -0.034123, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "STT", "relevance_score": "0.254973", "ticker_sentiment_score": "0.031616", "ticker_sentiment_label": "Neutral"}, {"ticker": "KAMN", "relevance_score": "0.129168", "ticker_sentiment_score": "0.115892", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.129168", "ticker_sentiment_score": "0.092305", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.129168", "ticker_sentiment_score": "0.364054", "ticker_sentiment_label": "Bullish"}, {"ticker": "BKR", "relevance_score": "0.064797", "ticker_sentiment_score": "0.067255", "ticker_sentiment_label": "Neutral"}, {"ticker": "CISS", "relevance_score": "0.129168", "ticker_sentiment_score": "0.127673", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.129168", "ticker_sentiment_score": "-0.216193", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BSTT", "relevance_score": "0.064797", "ticker_sentiment_score": "0.311123", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TCN", "relevance_score": "0.129168", "ticker_sentiment_score": "0.364054", "ticker_sentiment_label": "Bullish"}]}, {"title": "Dow Jumps 150 Points; US Consumer Sentiment Surges In January - Anitra  ( AMEX:AZTR ) , C3is  ( NASDAQ:CISS ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36698245/dow-jumps-150-points-us-consumer-sentiment-surges-in-january", "time_published": "20240119T170111", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Friday. The Dow traded up 0.41% to 37,621.27 while the NASDAQ rose 0.66% to 15,154.43. The S&P 500 also rose, gaining, 0.46% to 4,803.12. Information technology shares rose by 1.1% on Friday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/19/image28.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.2"}], "overall_sentiment_score": -0.048655, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KAMN", "relevance_score": "0.151539", "ticker_sentiment_score": "0.126408", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.151539", "ticker_sentiment_score": "0.101454", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.151539", "ticker_sentiment_score": "0.393931", "ticker_sentiment_label": "Bullish"}, {"ticker": "CISS", "relevance_score": "0.151539", "ticker_sentiment_score": "0.139242", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.235376", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BSTT", "relevance_score": "0.076115", "ticker_sentiment_score": "0.315178", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TCN", "relevance_score": "0.151539", "ticker_sentiment_score": "0.393931", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why Processa Pharmaceuticals  ( PCSA )  Stock Is Skyrocketing - Processa Pharma  ( NASDAQ:PCSA ) ", "url": "https://www.benzinga.com/news/24/01/36696774/why-processa-pharmaceuticals-pcsa-stock-is-skyrocketing", "time_published": "20240119T152458", "authors": ["Henry Khederian"], "summary": "Processa Pharmaceuticals Inc PCSA shares are trading higher by 36.9% to $0.28 during Friday's session after the company announced plans to expand the development of Next Generation Capecitabine ( \"NGC-Cap\" ) into the treatment of advanced or metastatic breast cancer.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/woman-6318447.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.02467, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.613172", "ticker_sentiment_score": "0.112519", "ticker_sentiment_label": "Neutral"}]}, {"title": "US Stocks Higher; Schlumberger Earnings Beat Estimates - Accelerate Diagnostics  ( NASDAQ:AXDX ) , C3is  ( NASDAQ:CISS ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36696062/us-stocks-higher-schlumberger-earnings-beat-estimates", "time_published": "20240119T145335", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Dow traded up 0.18% to 37,536.76 while the NASDAQ rose 0.38% to 15,113.04. The S&P 500 also rose, gaining, 0.19% to 4,790.00.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/19/image45.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.682689"}], "overall_sentiment_score": -0.031837, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KAMN", "relevance_score": "0.143843", "ticker_sentiment_score": "0.122612", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.214304", "ticker_sentiment_score": "0.014607", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.143843", "ticker_sentiment_score": "0.112653", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.214304", "ticker_sentiment_score": "0.493871", "ticker_sentiment_label": "Bullish"}, {"ticker": "SLB", "relevance_score": "0.143843", "ticker_sentiment_score": "0.093667", "ticker_sentiment_label": "Neutral"}, {"ticker": "CISS", "relevance_score": "0.143843", "ticker_sentiment_score": "0.135068", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.143843", "ticker_sentiment_score": "-0.228484", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BSTT", "relevance_score": "0.072217", "ticker_sentiment_score": "0.319572", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TCN", "relevance_score": "0.214304", "ticker_sentiment_score": "0.493871", "ticker_sentiment_label": "Bullish"}]}, {"title": "Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer", "url": "https://www.globenewswire.com/news-release/2024/01/19/2812259/0/en/Processa-Pharmaceuticals-Announces-Expansion-of-NGC-Cap-Program-into-Advanced-or-Metastatic-Breast-Cancer.html", "time_published": "20240119T124500", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "FDA and Processa agree to expand NGC-Cap development into breast cancer providing a more efficient path to approval ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.081404, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.112885", "ticker_sentiment_score": "0.011693", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Surges Over 100 Points; M&T Bank Posts Weak Earnings - Agrify  ( NASDAQ:AGFY ) , Aravive  ( NASDAQ:ARAV ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36684186/dow-surges-over-100-points-m-t-bank-posts-weak-earnings", "time_published": "20240118T192554", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.35% to 37,398.50 while the NASDAQ rose 1.16% to 15,027.63. The S&P 500 also rose, gaining, 0.67% to 4,770.73. Information technology shares rose by 2% on ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/18/image12.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.028855, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.062761", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.186738", "ticker_sentiment_score": "0.015613", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAMP", "relevance_score": "0.125134", "ticker_sentiment_score": "0.188598", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AGFY", "relevance_score": "0.125134", "ticker_sentiment_score": "0.213047", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EHTH", "relevance_score": "0.186738", "ticker_sentiment_score": "-0.126283", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKHSF", "relevance_score": "0.062761", "ticker_sentiment_score": "0.189193", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ARAV", "relevance_score": "0.186738", "ticker_sentiment_score": "0.127755", "ticker_sentiment_label": "Neutral"}]}, {"title": "Crude Oil Rises Over 1%; Processa Pharmaceuticals Shares Slide - Agrify  ( NASDAQ:AGFY ) , Aravive  ( NASDAQ:ARAV ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36681909/crude-oil-rises-over-1-processa-pharmaceuticals-shares-slide", "time_published": "20240118T170019", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 1% on Thursday. The Dow traded down 0.02% to 37,257.79 while the NASDAQ rose 1.19% to 15,032.26. The S&P 500 also rose, gaining, 0.49% to 4,762.36. Information technology shares rose by 2% on ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/18/crude_oil_4-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.019325, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.070935", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.210579", "ticker_sentiment_score": "0.01711", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFY", "relevance_score": "0.14131", "ticker_sentiment_score": "0.226276", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EHTH", "relevance_score": "0.210579", "ticker_sentiment_score": "-0.138282", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKHSF", "relevance_score": "0.070935", "ticker_sentiment_score": "0.190336", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ARAV", "relevance_score": "0.210579", "ticker_sentiment_score": "0.13989", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.14131", "ticker_sentiment_score": "0.338197", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Processa Pharmaceuticals  ( PCSA )  Shares Are Nosediving - Processa Pharma  ( NASDAQ:PCSA ) ", "url": "https://www.benzinga.com/news/24/01/36680527/why-processa-pharmaceuticals-pcsa-shares-are-nosediving", "time_published": "20240118T155800", "authors": ["Henry Khederian"], "summary": "Processa Pharmaceuticals Inc PCSA shares are trading lower by 23% to $0.21 during Thursday's session after the company announced it will effect a 1-for-20 reverse stock split. The 1-for-20 reverse stock split is intended to meet Nasdaq's minimum bid price requirement.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/stock-market-6693060_2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.098743, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.757528", "ticker_sentiment_score": "-0.166268", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Nasdaq Jumps Over 100 Points; US Jobless Claims Fall To 187,000 - Agrify  ( NASDAQ:AGFY ) , Aravive  ( NASDAQ:ARAV ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36679077/nasdaq-jumps-over-100-points-us-jobless-claims-fall-to-187-000", "time_published": "20240118T144720", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.33% to 37,143.30 while the NASDAQ rose 0.97% to 15,000.30. The S&P 500 also rose, gaining, 0.43% to 4,759.68.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/18/image33.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.038556, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.079921", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCAC", "relevance_score": "0.159043", "ticker_sentiment_score": "0.102504", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELU", "relevance_score": "0.159043", "ticker_sentiment_score": "0.228776", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCSA", "relevance_score": "0.236588", "ticker_sentiment_score": "0.018756", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYT", "relevance_score": "0.159043", "ticker_sentiment_score": "0.23498", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AGFY", "relevance_score": "0.236588", "ticker_sentiment_score": "0.153352", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ARAV", "relevance_score": "0.236588", "ticker_sentiment_score": "0.153352", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split", "url": "https://www.globenewswire.com/news-release/2024/01/18/2811452/0/en/Processa-Pharmaceuticals-to-Effect-a-1-for-20-Reverse-Stock-Split.html", "time_published": "20240118T124500", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Jan. 18, 2024 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.241711, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.154703", "ticker_sentiment_score": "-0.00407", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present at the Biotech Showcase 2024", "url": "https://www.globenewswire.com/news-release/2024/01/02/2802968/0/en/Processa-Pharmaceuticals-to-Present-at-the-Biotech-Showcase-2024.html", "time_published": "20240102T220600", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.197138, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.218161", "ticker_sentiment_score": "-0.017346", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Rocket Lab Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Advent Technologies Hldgs  ( NASDAQ:ADN ) , Asset Entities  ( NASDAQ:ASST ) ", "url": "https://www.benzinga.com/news/23/12/36360331/why-rocket-lab-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket", "time_published": "20231222T125831", "authors": ["Avi Kapoor"], "summary": "Shares of Rocket Lab USA, Inc. RKLB shares rose sharply in pre-market trading after the company announced a new $515 million contract with a U.S. government customer.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/22/image_3.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.897321"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.099706, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CNEY", "relevance_score": "0.127795", "ticker_sentiment_score": "0.21404", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RTC", "relevance_score": "0.190667", "ticker_sentiment_score": "-0.213088", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PCSA", "relevance_score": "0.190667", "ticker_sentiment_score": "0.140025", "ticker_sentiment_label": "Neutral"}, {"ticker": "SXTP", "relevance_score": "0.127795", "ticker_sentiment_score": "-0.222498", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NKE", "relevance_score": "0.127795", "ticker_sentiment_score": "0.079237", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.190667", "ticker_sentiment_score": "0.190214", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WLGS", "relevance_score": "0.127795", "ticker_sentiment_score": "-0.050977", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.190667", "ticker_sentiment_score": "0.192045", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CNXA", "relevance_score": "0.127795", "ticker_sentiment_score": "0.195134", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SHPH", "relevance_score": "0.127795", "ticker_sentiment_score": "0.195134", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ASST", "relevance_score": "0.190667", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.190667", "ticker_sentiment_score": "-0.014441", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTES", "relevance_score": "0.127795", "ticker_sentiment_score": "-0.130768", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBNH", "relevance_score": "0.190667", "ticker_sentiment_score": "0.15124", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NCPL", "relevance_score": "0.190667", "ticker_sentiment_score": "0.076762", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.064104", "ticker_sentiment_score": "0.061713", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.127795", "ticker_sentiment_score": "0.090721", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.127795", "ticker_sentiment_score": "-0.054939", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAL", "relevance_score": "0.127795", "ticker_sentiment_score": "-0.077284", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Innovative Cancer Treatment Demonstrates Higher Efficacy at Lower Doses Over Capecitabine - Processa Pharma  ( NASDAQ:PCSA ) ", "url": "https://www.benzinga.com/general/biotech/23/12/36311191/processa-pharmaceuticals-innovative-cancer-treatment-demonstrates-higher-efficacy-at-lower-doses-", "time_published": "20231219T204118", "authors": ["Vandana Singh"], "summary": "Processa Pharmaceuticals Inc PCSA provides an interim analysis from its Phase 1b Next Generation Capecitabine ( NGC-Cap ) study.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/19/pcsa.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.052418, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.350564", "ticker_sentiment_score": "0.163882", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine", "url": "https://www.globenewswire.com/news-release/2023/12/19/2798574/0/en/Processa-Pharmaceuticals-Provides-Interim-Analysis-from-Ongoing-Phase-1b-Trial-of-Next-Generation-Capecitabine-Showing-Improved-Safety-Over-Capecitabine.html", "time_published": "20231219T140000", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "FDA acknowledges that NGC-Cap is a New Chemical Entity given the changes to metabolism and distribution of its major metabolite ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.168608, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.092095", "ticker_sentiment_score": "0.008534", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady - Blackboxstocks  ( NASDAQ:BLBX ) , C4 Therapeutics  ( NASDAQ:CCCC ) ", "url": "https://www.benzinga.com/news/earnings/23/12/36223562/dow-jumps-over-200-points-federal-reserve-holds-interest-rates-steady", "time_published": "20231213T193056", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The Dow traded up 0.58% to 36,789.77 while the NASDAQ rose 0.63% to 14,624.74. The S&P 500 also rose, gaining, 0.62% to 4,672.48. Utilities shares rose by 1.2% on Wednesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/13/federal_reserve2_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": -0.016918, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.132733", "ticker_sentiment_score": "-0.20352", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RSLS", "relevance_score": "0.132733", "ticker_sentiment_score": "0.309603", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BLBX", "relevance_score": "0.132733", "ticker_sentiment_score": "0.140846", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCC", "relevance_score": "0.197951", "ticker_sentiment_score": "0.165615", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STTK", "relevance_score": "0.132733", "ticker_sentiment_score": "0.259657", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet - Blackboxstocks  ( NASDAQ:BLBX ) , C4 Therapeutics  ( NASDAQ:CCCC ) ", "url": "https://www.benzinga.com/news/earnings/23/12/36220335/crude-oil-gains-1-5-blackboxstocks-shares-plummet", "time_published": "20231213T170550", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose, gaining, 0.20% to 4,653.07. Real estate shares rose by 1% on Wednesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/13/image49.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": 0.002421, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.141726", "ticker_sentiment_score": "-0.210589", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RSLS", "relevance_score": "0.141726", "ticker_sentiment_score": "0.319914", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BLBX", "relevance_score": "0.141726", "ticker_sentiment_score": "0.146069", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCC", "relevance_score": "0.211191", "ticker_sentiment_score": "0.17397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STTK", "relevance_score": "0.141726", "ticker_sentiment_score": "0.268506", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "What's Going On With Processa Pharmaceuticals  ( PCSA )  Stock? - Processa Pharma  ( NASDAQ:PCSA ) ", "url": "https://www.benzinga.com/news/23/12/36216822/whats-going-on-with-processa-pharmaceuticals-pcsa-stock", "time_published": "20231213T144255", "authors": ["Henry Khederian"], "summary": "Processa Pharmaceuticals Inc PCSA shares are trading lower by 21.7% to $0.64 Wednesday morning after the company said it recently had a meeting with the FDA about their Next Generation Capecitabine ( NGC-Cap ) for cancer patients. The FDA provided guidance on designing the Phase 2 study, ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/13/vaccine-4892048.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.10969, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.727604", "ticker_sentiment_score": "-0.278045", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "US Stocks Mixed; Producer Prices Unchanged For November - Blackboxstocks  ( NASDAQ:BLBX ) , C4 Therapeutics  ( NASDAQ:CCCC ) ", "url": "https://www.benzinga.com/news/earnings/23/12/36216825/us-stocks-mixed-producer-prices-unchanged-for-november", "time_published": "20231213T144014", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 36,561.18 while the NASDAQ rose 0.42% to 14,594.61. The S&P 500 also rose, gaining, 0.14% to 4,650.04.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/13/image44.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.095404, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.146469", "ticker_sentiment_score": "-0.099483", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSLS", "relevance_score": "0.146469", "ticker_sentiment_score": "0.32556", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BLBX", "relevance_score": "0.218161", "ticker_sentiment_score": "0.239128", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CCCC", "relevance_score": "0.218161", "ticker_sentiment_score": "0.178397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HYW", "relevance_score": "0.146469", "ticker_sentiment_score": "0.335439", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STTK", "relevance_score": "0.146469", "ticker_sentiment_score": "0.273366", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine", "url": "https://www.globenewswire.com/news-release/2023/12/13/2795618/0/en/Processa-Pharmaceuticals-Announces-Successful-Phase-2-Meeting-with-FDA-for-Next-Generation-Capecitabine.html", "time_published": "20231213T140000", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "FDA provides guidance on Phase 2 design and Processa to continue with pre-study activities for Phase 2 trial ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.197334, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.13637", "ticker_sentiment_score": "0.002555", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket - African Agriculture Hldgs  ( NASDAQ:AAGR ) , AcelRx Pharmaceuticals  ( NASDAQ:ACRX ) ", "url": "https://www.benzinga.com/news/23/12/36174622/why-green-giant-shares-are-trading-lower-by-around-37-here-are-20-stocks-moving-premarket", "time_published": "20231211T125928", "authors": ["Avi Kapoor"], "summary": "Shares of Green Giant Inc. GGE fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading. NextPlay Technologies, Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/11/image21.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.017039, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HUM", "relevance_score": "0.14131", "ticker_sentiment_score": "0.259492", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISUN", "relevance_score": "0.14131", "ticker_sentiment_score": "-0.234979", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NAAS", "relevance_score": "0.210579", "ticker_sentiment_score": "0.213474", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NXTP", "relevance_score": "0.210579", "ticker_sentiment_score": "0.135067", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGE", "relevance_score": "0.210579", "ticker_sentiment_score": "-0.035591", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.14131", "ticker_sentiment_score": "0.043971", "ticker_sentiment_label": "Neutral"}, {"ticker": "CI", "relevance_score": "0.14131", "ticker_sentiment_score": "0.259492", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ONTX", "relevance_score": "0.210579", "ticker_sentiment_score": "0.296785", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "M", "relevance_score": "0.14131", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRVS", "relevance_score": "0.14131", "ticker_sentiment_score": "0.134969", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAGR", "relevance_score": "0.14131", "ticker_sentiment_score": "-0.231203", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ACRX", "relevance_score": "0.14131", "ticker_sentiment_score": "0.041248", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAN", "relevance_score": "0.14131", "ticker_sentiment_score": "0.16706", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NIR", "relevance_score": "0.210579", "ticker_sentiment_score": "0.246646", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NUZE", "relevance_score": "0.14131", "ticker_sentiment_score": "-0.058153", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPBT", "relevance_score": "0.14131", "ticker_sentiment_score": "-0.081909", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.210579", "ticker_sentiment_score": "0.063397", "ticker_sentiment_label": "Neutral"}, {"ticker": "XFOR", "relevance_score": "0.210579", "ticker_sentiment_score": "-0.274986", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CYN", "relevance_score": "0.210579", "ticker_sentiment_score": "-0.193292", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EFTR", "relevance_score": "0.210579", "ticker_sentiment_score": "-0.124952", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook", "url": "https://www.globenewswire.com/news-release/2023/11/29/2787726/0/en/Processa-Pharmaceuticals-Issues-Letter-to-Shareholders-Highlighting-Corporate-Strategy-Drug-Pipeline-and-Outlook.html", "time_published": "20231129T131500", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Nov. 29, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.248023, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.071428", "ticker_sentiment_score": "-0.012226", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket - Anghami  ( NASDAQ:ANGH ) , AgileThought  ( NASDAQ:AGIL ) ", "url": "https://www.benzinga.com/news/23/11/35914672/why-guess-shares-are-trading-lower-by-around-15-here-are-20-stocks-moving-premarket", "time_published": "20231122T125806", "authors": ["Lisa Levin"], "summary": "Shares of Guess?, Inc. GES shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance below estimates.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/22/guess_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.897321"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.994953"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.075456, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SASI", "relevance_score": "0.13459", "ticker_sentiment_score": "-0.005042", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.13459", "ticker_sentiment_score": "-0.421318", "ticker_sentiment_label": "Bearish"}, {"ticker": "CNTB", "relevance_score": "0.13459", "ticker_sentiment_score": "0.118288", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEV", "relevance_score": "0.200688", "ticker_sentiment_score": "-0.271502", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CYCC", "relevance_score": "0.13459", "ticker_sentiment_score": "0.045443", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCON", "relevance_score": "0.13459", "ticker_sentiment_score": "-0.056525", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOGN", "relevance_score": "0.13459", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.13459", "ticker_sentiment_score": "-0.15515", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATHE", "relevance_score": "0.13459", "ticker_sentiment_score": "-0.452535", "ticker_sentiment_label": "Bearish"}, {"ticker": "ANGH", "relevance_score": "0.200688", "ticker_sentiment_score": "-0.040594", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGD", "relevance_score": "0.200688", "ticker_sentiment_score": "0.295614", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SOL", "relevance_score": "0.13459", "ticker_sentiment_score": "-0.175517", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GES", "relevance_score": "0.265378", "ticker_sentiment_score": "0.230161", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AGIL", "relevance_score": "0.13459", "ticker_sentiment_score": "0.333109", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HSCS", "relevance_score": "0.13459", "ticker_sentiment_score": "0.14595", "ticker_sentiment_label": "Neutral"}, {"ticker": "BODY", "relevance_score": "0.200688", "ticker_sentiment_score": "-0.219248", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CAPT", "relevance_score": "0.13459", "ticker_sentiment_score": "0.315262", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BNRG", "relevance_score": "0.13459", "ticker_sentiment_score": "0.200129", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WHLR", "relevance_score": "0.13459", "ticker_sentiment_score": "0.045443", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil Thompson", "url": "https://www.globenewswire.com/news-release/2023/11/13/2779363/0/en/Processa-Pharmaceuticals-Inc-Mourns-the-Sudden-Passing-of-Board-Member-Virgil-Thompson.html", "time_published": "20231113T184000", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "Hanover, MD., Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) announced today with great sadness that Virgil Thompson, Director, passed away unexpectedly on November 9, 2023. Mr. Thompson served on our Board of Directors since we were formed in 2017 and was ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.239541, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.177802", "ticker_sentiment_score": "-0.017685", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas", "url": "https://www.globenewswire.com/news-release/2023/11/09/2777341/0/en/Processa-Pharmaceuticals-to-Present-at-the-20th-Orphan-Drugs-and-Rare-Diseases-Global-Congress-2023-Americas.html", "time_published": "20231109T131500", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Nov. 09, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.184044, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.233556", "ticker_sentiment_score": "-0.0423", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders", "url": "https://www.globenewswire.com/news-release/2023/11/01/2771155/0/en/Processa-Pharmaceuticals-Announces-Formation-of-Oncology-Advisory-Board-with-Renowned-Key-Opinion-Leaders.html", "time_published": "20231101T121500", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "Company To Leverage World-Class Oncology Advisory Board in the Design of Oncology Trial Protocols, Including the Anticipated Phase 2 Trial for ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.009794, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.085527", "ticker_sentiment_score": "-0.01155", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Gastroparesis Treatment Market is Expected to Grow Revenue up to USD 11.09 Billion By 2030 with a Growing CAGR of 3.3% | Infinium Global Research", "url": "https://www.prnewswire.com/news-releases/global-gastroparesis-treatment-market-is-expected-to-grow-revenue-up-to-usd-11-09-billion-by-2030-with-a-growing-cagr-of-3-3--infinium-global-research-301969986.html", "time_published": "20231027T093000", "authors": ["Infinium Global Research"], "summary": "Global Gastroparesis Treatment Market is Expected to Grow Revenue up to USD 11.09 Billion By 2030 with a Growing ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2244132/Infinium_Global_Research_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.174067, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TBPH", "relevance_score": "0.041682", "ticker_sentiment_score": "-0.084698", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.041682", "ticker_sentiment_score": "-0.084698", "ticker_sentiment_label": "Neutral"}, {"ticker": "III", "relevance_score": "0.041682", "ticker_sentiment_score": "0.165794", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDT", "relevance_score": "0.041682", "ticker_sentiment_score": "-0.084698", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOK", "relevance_score": "0.041682", "ticker_sentiment_score": "-0.084698", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSK", "relevance_score": "0.041682", "ticker_sentiment_score": "-0.084698", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAK", "relevance_score": "0.041682", "ticker_sentiment_score": "-0.084698", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Knight-Swift Transportation Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Aravive  ( NASDAQ:ARAV ) , American Well  ( NYSE:AMWL ) ", "url": "https://www.benzinga.com/news/23/10/35347610/why-knight-swift-transportation-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-pre", "time_published": "20231020T114219", "authors": ["Lisa Levin"], "summary": "XORTX Therapeutics Inc. XRTX shares surged 95.5% to $0.6226 in pre-market trading after jumping 34% on Thursday. Urgent.ly Inc. ULY shares rose 61.6% to $8.89 in pre-market trading after falling around 52% on Thursday. -Urgent.ly announced the closing of its acquisition of Otonomo Technologies Ltd.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/20/image21.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.865346"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.106029, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LAES", "relevance_score": "0.193723", "ticker_sentiment_score": "0.104058", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTMO", "relevance_score": "0.06515", "ticker_sentiment_score": "0.021115", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUEN", "relevance_score": "0.129866", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.129866", "ticker_sentiment_score": "-0.077973", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQT", "relevance_score": "0.193723", "ticker_sentiment_score": "0.190418", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILAG", "relevance_score": "0.129866", "ticker_sentiment_score": "0.071833", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASST", "relevance_score": "0.193723", "ticker_sentiment_score": "-0.034526", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICI", "relevance_score": "0.06515", "ticker_sentiment_score": "0.147255", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEDG", "relevance_score": "0.193723", "ticker_sentiment_score": "-0.197234", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KNX", "relevance_score": "0.129866", "ticker_sentiment_score": "0.434182", "ticker_sentiment_label": "Bullish"}, {"ticker": "UK", "relevance_score": "0.193723", "ticker_sentiment_score": "0.215562", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCEL", "relevance_score": "0.129866", "ticker_sentiment_score": "-0.051417", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRTX", "relevance_score": "0.129866", "ticker_sentiment_score": "0.159934", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ARAV", "relevance_score": "0.129866", "ticker_sentiment_score": "0.215808", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ICU", "relevance_score": "0.129866", "ticker_sentiment_score": "0.189662", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDAI", "relevance_score": "0.193723", "ticker_sentiment_score": "-0.121484", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOWL", "relevance_score": "0.193723", "ticker_sentiment_score": "0.221545", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISRG", "relevance_score": "0.129866", "ticker_sentiment_score": "-0.185973", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMWL", "relevance_score": "0.129866", "ticker_sentiment_score": "0.14219", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDOS", "relevance_score": "0.06515", "ticker_sentiment_score": "0.121175", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHLR", "relevance_score": "0.129866", "ticker_sentiment_score": "0.044566", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Akso Health Group  ( NASDAQ:AHG ) , AGBA Group Holding  ( NASDAQ:AGBA ) ", "url": "https://www.benzinga.com/news/23/10/35284666/why-vistagen-therapeutics-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket", "time_published": "20231017T121251", "authors": ["Lisa Levin"], "summary": "SciSparc Ltd. SPRC shares surged 79.5% to $5.08 in pre-market trading after falling around 7% on Monday. SciSparc recently regained compliance with the Nasdaq Minimum Bid Price Notification. WiSA Technologies, Inc. WISA shares rose 76.4% to $0.4380 in pre-market trading after falling 40% on ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/17/image22.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.036812, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AHG", "relevance_score": "0.227007", "ticker_sentiment_score": "0.177253", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WNW", "relevance_score": "0.152499", "ticker_sentiment_score": "-0.095574", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.152499", "ticker_sentiment_score": "-0.060975", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNET", "relevance_score": "0.152499", "ticker_sentiment_score": "-0.24138", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMAM", "relevance_score": "0.227007", "ticker_sentiment_score": "-0.146727", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRC", "relevance_score": "0.227007", "ticker_sentiment_score": "0.035387", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISA", "relevance_score": "0.227007", "ticker_sentiment_score": "-0.005496", "ticker_sentiment_label": "Neutral"}, {"ticker": "XXII", "relevance_score": "0.152499", "ticker_sentiment_score": "-0.056562", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAGX", "relevance_score": "0.152499", "ticker_sentiment_score": "0.355503", "ticker_sentiment_label": "Bullish"}, {"ticker": "NCNA", "relevance_score": "0.227007", "ticker_sentiment_score": "-0.342681", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VTGN", "relevance_score": "0.152499", "ticker_sentiment_score": "0.107579", "ticker_sentiment_label": "Neutral"}, {"ticker": "YGMZ", "relevance_score": "0.152499", "ticker_sentiment_score": "-0.175993", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NTCT", "relevance_score": "0.152499", "ticker_sentiment_score": "-0.136955", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVVE", "relevance_score": "0.152499", "ticker_sentiment_score": "0.214436", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AGBA", "relevance_score": "0.152499", "ticker_sentiment_score": "-0.223426", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATHX", "relevance_score": "0.227007", "ticker_sentiment_score": "0.247856", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JG", "relevance_score": "0.152499", "ticker_sentiment_score": "0.213221", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AVGR", "relevance_score": "0.152499", "ticker_sentiment_score": "0.134035", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Aldeyra Therapeutics  ( NASDAQ:ALDX ) , Alignment Healthcare  ( NASDAQ:ALHC ) ", "url": "https://www.benzinga.com/news/23/10/35272489/why-streamline-health-solutions-shares-are-trading-lower-by-over-68-here-are-other-stocks-moving-in", "time_published": "20231016T170953", "authors": ["Lisa Levin"], "summary": "MingZhu Logistics Holdings Limited YGMZ shares gained 64% to $0.7798 after gaining more than 10% on Friday. PCTEL, Inc. PCTI climbed 47.3% to $6.86. On Friday, Amphenol Corp APH inked a deal to acquire PCTEL for around $139.7 million. Almacenes \u00c9xito S.A. EXTO shares rose 32.6% to $6.66.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/16/image19.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.0049, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RERE", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SASI", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.234441", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FAZE", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.051282", "ticker_sentiment_label": "Neutral"}, {"ticker": "MODD", "relevance_score": "0.076236", "ticker_sentiment_score": "0.348025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCTI", "relevance_score": "0.114137", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.175071", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CLOV", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "NFTG", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "RDHL", "relevance_score": "0.076236", "ticker_sentiment_score": "0.044686", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRZO", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.054605", "ticker_sentiment_label": "Neutral"}, {"ticker": "YGMZ", "relevance_score": "0.076236", "ticker_sentiment_score": "0.289453", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CNSP", "relevance_score": "0.076236", "ticker_sentiment_score": "0.348025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SECO", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.334701", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ENSC", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNSL", "relevance_score": "0.076236", "ticker_sentiment_score": "0.12345", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.02076", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "ELYS", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "PCSA", "relevance_score": "0.076236", "ticker_sentiment_score": "0.169195", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NOTV", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.071984", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.080856", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.076236", "ticker_sentiment_score": "0.348025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VS", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.209567", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NXL", "relevance_score": "0.114137", "ticker_sentiment_score": "0.148778", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.09675", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNTS", "relevance_score": "0.076236", "ticker_sentiment_score": "0.499776", "ticker_sentiment_label": "Bullish"}, {"ticker": "AMAM", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.060629", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLTX", "relevance_score": "0.076236", "ticker_sentiment_score": "0.092002", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDI", "relevance_score": "0.114137", "ticker_sentiment_score": "0.088685", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.076236", "ticker_sentiment_score": "0.348025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TNGX", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "EXTO", "relevance_score": "0.076236", "ticker_sentiment_score": "0.242611", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZAPP", "relevance_score": "0.076236", "ticker_sentiment_score": "0.07953", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.234441", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VSTO", "relevance_score": "0.076236", "ticker_sentiment_score": "0.02304", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.038162", "ticker_sentiment_score": "0.063334", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNY", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.504896", "ticker_sentiment_label": "Bearish"}, {"ticker": "CBIO", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.121926", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.051282", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.027399", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALDX", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.020405", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETWO", "relevance_score": "0.114137", "ticker_sentiment_score": "0.133347", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQR", "relevance_score": "0.114137", "ticker_sentiment_score": "0.073097", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVLP", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.118813", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.076236", "ticker_sentiment_score": "0.122434", "ticker_sentiment_label": "Neutral"}, {"ticker": "PROC", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "ALHC", "relevance_score": "0.076236", "ticker_sentiment_score": "0.362377", "ticker_sentiment_label": "Bullish"}, {"ticker": "MANU", "relevance_score": "0.076236", "ticker_sentiment_score": "0.038136", "ticker_sentiment_label": "Neutral"}, {"ticker": "APH", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPST", "relevance_score": "0.076236", "ticker_sentiment_score": "0.348025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STRM", "relevance_score": "0.076236", "ticker_sentiment_score": "0.092981", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAOV", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket", "url": "https://markets.businessinsider.com/news/stocks/why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket-1032708380", "time_published": "20231016T131535", "authors": [], "summary": "Why ContraFect Shares Are Trading Higher By Around 30%. Here Are 20 Stocks Moving Premarket - Markets Insider ...", "banner_image": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/10/16/image21.jpeg", "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.752319"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.002452, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SFT", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.036651", "ticker_sentiment_label": "Neutral"}, {"ticker": "SASI", "relevance_score": "0.105604", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.105604", "ticker_sentiment_score": "0.157008", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMAM", "relevance_score": "0.105604", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAZE", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.050283", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQR", "relevance_score": "0.105604", "ticker_sentiment_score": "0.17774", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCTI", "relevance_score": "0.105604", "ticker_sentiment_score": "0.106937", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.240048", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BNTX", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.240048", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RDHL", "relevance_score": "0.105604", "ticker_sentiment_score": "0.04295", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQB", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.326449", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "COST", "relevance_score": "0.105604", "ticker_sentiment_score": "0.17774", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRZO", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.052781", "ticker_sentiment_label": "Neutral"}, {"ticker": "YGMZ", "relevance_score": "0.105604", "ticker_sentiment_score": "0.273297", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CFRX", "relevance_score": "0.105604", "ticker_sentiment_score": "0.087402", "ticker_sentiment_label": "Neutral"}, {"ticker": "SECO", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.298031", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APH", "relevance_score": "0.105604", "ticker_sentiment_score": "0.106937", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.105604", "ticker_sentiment_score": "0.29475", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.050283", "ticker_sentiment_label": "Neutral"}, {"ticker": "VS", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.266018", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket - Ambrx Biopharma  ( NASDAQ:AMAM ) , Amphenol  ( NYSE:APH ) ", "url": "https://www.benzinga.com/news/23/10/35266067/why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket", "time_published": "20231016T124712", "authors": ["Lisa Levin"], "summary": "LQR House Inc. LQR shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, securing Von Payne Whiskey's presence on store shelves. Processa Pharmaceuticals, Inc. PCSA shares rose 84.4% to $0.8853 in pre-market trading after jumping 45% on Friday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/16/image21.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.82617"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.014639, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SFT", "relevance_score": "0.287762", "ticker_sentiment_score": "-0.047206", "ticker_sentiment_label": "Neutral"}, {"ticker": "SASI", "relevance_score": "0.194242", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.194242", "ticker_sentiment_score": "0.205479", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMAM", "relevance_score": "0.194242", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAZE", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.067054", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQR", "relevance_score": "0.194242", "ticker_sentiment_score": "0.238419", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCTI", "relevance_score": "0.287762", "ticker_sentiment_score": "0.187512", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EXTO", "relevance_score": "0.194242", "ticker_sentiment_score": "0.271112", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.097854", "ticker_sentiment_score": "-0.225147", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BNTX", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.318104", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RDHL", "relevance_score": "0.194242", "ticker_sentiment_score": "0.058057", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQB", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.405247", "ticker_sentiment_label": "Bearish"}, {"ticker": "COST", "relevance_score": "0.097854", "ticker_sentiment_score": "0.167429", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRZO", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.072285", "ticker_sentiment_label": "Neutral"}, {"ticker": "YGMZ", "relevance_score": "0.194242", "ticker_sentiment_score": "0.380189", "ticker_sentiment_label": "Bullish"}, {"ticker": "CFRX", "relevance_score": "0.194242", "ticker_sentiment_score": "0.117902", "ticker_sentiment_label": "Neutral"}, {"ticker": "MANU", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.10182", "ticker_sentiment_label": "Neutral"}, {"ticker": "SECO", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.406644", "ticker_sentiment_label": "Bearish"}, {"ticker": "APH", "relevance_score": "0.194242", "ticker_sentiment_score": "0.137587", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.194242", "ticker_sentiment_score": "0.365696", "ticker_sentiment_label": "Bullish"}, {"ticker": "BPTH", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.067054", "ticker_sentiment_label": "Neutral"}, {"ticker": "VS", "relevance_score": "0.287762", "ticker_sentiment_score": "-0.320657", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Top 3 Health Care Stocks That May Implode This Quarter - Acurx Pharmaceuticals  ( NASDAQ:ACXP ) , Cardinal Health  ( NYSE:CAH ) ", "url": "https://www.benzinga.com/news/23/10/35265545/top-3-health-care-stocks-that-may-implode-this-quarter", "time_published": "20231016T122829", "authors": ["Lisa Levin"], "summary": "The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/16/image15.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.309409, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACXP", "relevance_score": "0.345674", "ticker_sentiment_score": "0.608438", "ticker_sentiment_label": "Bullish"}, {"ticker": "PCSA", "relevance_score": "0.345674", "ticker_sentiment_score": "0.338", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CAH", "relevance_score": "0.498188", "ticker_sentiment_score": "0.533052", "ticker_sentiment_label": "Bullish"}]}, {"title": "Processa Pharmaceuticals to Present at the ThinkEquity Conference", "url": "https://www.globenewswire.com/news-release/2023/10/13/2760110/0/en/Processa-Pharmaceuticals-to-Present-at-the-ThinkEquity-Conference.html", "time_published": "20231013T170800", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Oct. 13, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.185855, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MAORF", "relevance_score": "0.078099", "ticker_sentiment_score": "0.010351", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.231332", "ticker_sentiment_score": "-0.018196", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving Premarket - AgriFORCE Growing Systems  ( NASDAQ:AGRI ) , Astra Space  ( NASDAQ:ASTR ) ", "url": "https://www.benzinga.com/news/23/09/34686199/why-rubicon-technologies-shares-are-trading-lower-by-over-7-here-are-20-stocks-moving-premarket", "time_published": "20230918T121035", "authors": ["Lisa Levin"], "summary": "T2 Biosystems, Inc. TTOO shares rose 44.4% to $0.4003 in pre-market trading. T2 Biosystems said it issued inducement awards to four new employees. Perspective Therapeutics, Inc. CATX shares rose 36.5% to $0.2799 in pre-market trading after falling 42% on Friday. SCWorx Corp.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/18/image16.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.002449, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.198221", "ticker_sentiment_score": "-0.073399", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWIN", "relevance_score": "0.198221", "ticker_sentiment_score": "-0.073399", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBT", "relevance_score": "0.293506", "ticker_sentiment_score": "-0.540472", "ticker_sentiment_label": "Bearish"}, {"ticker": "AVTX", "relevance_score": "0.293506", "ticker_sentiment_score": "0.520922", "ticker_sentiment_label": "Bullish"}, {"ticker": "TTOO", "relevance_score": "0.293506", "ticker_sentiment_score": "0.44886", "ticker_sentiment_label": "Bullish"}, {"ticker": "BTTX", "relevance_score": "0.198221", "ticker_sentiment_score": "-0.168849", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AWON", "relevance_score": "0.09989", "ticker_sentiment_score": "-0.297487", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UPTD", "relevance_score": "0.198221", "ticker_sentiment_score": "0.058956", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMMLD", "relevance_score": "0.198221", "ticker_sentiment_score": "-0.169193", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LIFW", "relevance_score": "0.198221", "ticker_sentiment_score": "-0.068089", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.293506", "ticker_sentiment_score": "0.055246", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQL", "relevance_score": "0.293506", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.198221", "ticker_sentiment_score": "0.04051", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.198221", "ticker_sentiment_score": "-0.287047", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WORX", "relevance_score": "0.198221", "ticker_sentiment_score": "0.298964", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TCBP", "relevance_score": "0.198221", "ticker_sentiment_score": "0.298964", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PIXY", "relevance_score": "0.198221", "ticker_sentiment_score": "0.058956", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference", "url": "https://www.globenewswire.com/news-release/2023/09/06/2738375/0/en/Processa-Pharmaceuticals-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html", "time_published": "20230906T121500", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, Sept. 06, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.17648, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.226301", "ticker_sentiment_score": "-0.017826", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Dell Technologies Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket - Acer Therapeutics  ( NASDAQ:ACER ) , Aditxt  ( NASDAQ:ADTX ) ", "url": "https://www.benzinga.com/news/23/09/34169746/why-dell-technologies-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarket", "time_published": "20230901T121610", "authors": ["Lisa Levin"], "summary": "Novo Integrated Sciences, Inc. NVOS rose 53.4% to $0.2147 in pre-market trading after the company announced it received an Underwriting Clearance Notice for a $70 million coupon. Eos Energy Enterprises, Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/01/dell_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.82617"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.132662, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FLGC", "relevance_score": "0.146469", "ticker_sentiment_score": "-0.059438", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.218161", "ticker_sentiment_score": "-0.144214", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.146469", "ticker_sentiment_score": "0.047755", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVOS", "relevance_score": "0.146469", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCL", "relevance_score": "0.218161", "ticker_sentiment_score": "0.486844", "ticker_sentiment_label": "Bullish"}, {"ticker": "ACER", "relevance_score": "0.218161", "ticker_sentiment_score": "-0.165238", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AXLA", "relevance_score": "0.146469", "ticker_sentiment_score": "0.04493", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.146469", "ticker_sentiment_score": "0.194367", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BDRX", "relevance_score": "0.146469", "ticker_sentiment_score": "-0.220762", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FGMC", "relevance_score": "0.073546", "ticker_sentiment_score": "-0.111911", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.073546", "ticker_sentiment_score": "0.006099", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADTX", "relevance_score": "0.218161", "ticker_sentiment_score": "-0.176753", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TIO", "relevance_score": "0.218161", "ticker_sentiment_score": "0.112334", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.146469", "ticker_sentiment_score": "0.367149", "ticker_sentiment_label": "Bullish"}, {"ticker": "ESTC", "relevance_score": "0.146469", "ticker_sentiment_score": "0.449395", "ticker_sentiment_label": "Bullish"}, {"ticker": "CGC", "relevance_score": "0.218161", "ticker_sentiment_score": "0.194804", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DELL", "relevance_score": "0.146469", "ticker_sentiment_score": "0.299527", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Care", "url": "https://www.globenewswire.com/news-release/2023/08/17/2727217/0/en/Processa-Pharmaceuticals-Provides-Data-Update-Supporting-a-Potential-Personalized-Treatment-Approach-for-Improved-Cancer-Care.html", "time_published": "20230817T120500", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "Interim analysis of Phase 1B data suggests Processa's novel chemotherapy treatment could improve safety and efficacy in more patients by individualizing the dosing regimen for each patient ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.180399, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.09186", "ticker_sentiment_score": "0.005386", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference", "url": "https://www.globenewswire.com/news-release/2023/08/10/2723192/0/en/Processa-Pharmaceuticals-to-Present-at-the-Sidoti-Co-Micro-Cap-Virtual-Conference.html", "time_published": "20230810T201500", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, Aug. 10, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.178892, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.229149", "ticker_sentiment_score": "-0.019858", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim", "url": "https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html", "time_published": "20230803T210100", "authors": ["LLP", "DelveInsight Business Research"], "summary": "Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.065734, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PBLA", "relevance_score": "0.041466", "ticker_sentiment_score": "-0.038518", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGEN", "relevance_score": "0.041466", "ticker_sentiment_score": "-0.038518", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.002722", "ticker_sentiment_label": "Neutral"}, {"ticker": "INNMF", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.020974", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.002722", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUP", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.062117", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.041466", "ticker_sentiment_score": "0.011869", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTX", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.020974", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.041466", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.020974", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVBXF", "relevance_score": "0.041466", "ticker_sentiment_score": "-0.022761", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTHF", "relevance_score": "0.041466", "ticker_sentiment_score": "0.013857", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNTH", "relevance_score": "0.02074", "ticker_sentiment_score": "0.035439", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVB", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.020974", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGEN", "relevance_score": "0.041466", "ticker_sentiment_score": "-0.017808", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.020974", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLDX", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.020974", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNBWY", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.002722", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.062117", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASPHF", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.020974", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCWB", "relevance_score": "0.041466", "ticker_sentiment_score": "0.013857", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCUS", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.020974", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.020974", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLCM", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.062117", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.062117", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBPCF", "relevance_score": "0.041466", "ticker_sentiment_score": "0.013857", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGMF", "relevance_score": "0.041466", "ticker_sentiment_score": "-0.002966", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.041466", "ticker_sentiment_score": "-0.038518", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.041466", "ticker_sentiment_score": "-0.038441", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGM", "relevance_score": "0.041466", "ticker_sentiment_score": "-0.038518", "ticker_sentiment_label": "Neutral"}, {"ticker": "IKNA", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.002722", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.041466", "ticker_sentiment_score": "0.013857", "ticker_sentiment_label": "Neutral"}, {"ticker": "INCY", "relevance_score": "0.041466", "ticker_sentiment_score": "-0.017808", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.041466", "ticker_sentiment_score": "0.013857", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.041466", "ticker_sentiment_score": "-0.038518", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYKOF", "relevance_score": "0.02074", "ticker_sentiment_score": "-0.002722", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why MicroVision Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket - Bone Biologics  ( NASDAQ:BBLG ) , Applied UV  ( NASDAQ:AUVI ) ", "url": "https://www.benzinga.com/news/23/06/32871563/why-microvision-shares-are-trading-higher-by-28-here-are-20-stocks-moving-premarket", "time_published": "20230615T120517", "authors": ["Lisa Levin"], "summary": "EdtechX Holdings Acquisition Corp. II EDTX shares gained 139.8% to $26.54 in pre-market trading. BitNile Metaverse, Inc. BNMV shares surged 38.5% to $1.80 in pre-market trading. BitNile.com said it has begun generating revenue from social gaming and Metaverse ads.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/15/microvision_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.174086, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BWV", "relevance_score": "0.222157", "ticker_sentiment_score": "0.371871", "ticker_sentiment_label": "Bullish"}, {"ticker": "LAES", "relevance_score": "0.149192", "ticker_sentiment_score": "-0.015279", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.149192", "ticker_sentiment_score": "0.248436", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BGNE", "relevance_score": "0.222157", "ticker_sentiment_score": "-0.029557", "ticker_sentiment_label": "Neutral"}, {"ticker": "DATS", "relevance_score": "0.149192", "ticker_sentiment_score": "-0.223105", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BBLG", "relevance_score": "0.149192", "ticker_sentiment_score": "0.064772", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.222157", "ticker_sentiment_score": "-0.139179", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEJU", "relevance_score": "0.149192", "ticker_sentiment_score": "0.210368", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BNMV", "relevance_score": "0.149192", "ticker_sentiment_score": "0.115064", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCS", "relevance_score": "0.222157", "ticker_sentiment_score": "-0.043348", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.045659", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVA", "relevance_score": "0.222157", "ticker_sentiment_score": "0.192583", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OWLT", "relevance_score": "0.149192", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.149192", "ticker_sentiment_score": "0.211686", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MVIS", "relevance_score": "0.222157", "ticker_sentiment_score": "0.311917", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AUVI", "relevance_score": "0.149192", "ticker_sentiment_score": "0.158307", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SONN", "relevance_score": "0.149192", "ticker_sentiment_score": "0.341304", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JG", "relevance_score": "0.149192", "ticker_sentiment_score": "0.024375", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNON", "relevance_score": "0.222157", "ticker_sentiment_score": "0.233934", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Next Generation Chemotherapy: Improved Treatment for More Patients", "url": "https://www.globenewswire.com/news-release/2023/06/14/2688466/0/en/Next-Generation-Chemotherapy-Improved-Treatment-for-More-Patients.html", "time_published": "20230614T201500", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, June 14, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.197748, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.212425", "ticker_sentiment_score": "-0.018748", "ticker_sentiment_label": "Neutral"}]}, {"title": "Longeveron Welcomes Three New Prominent Board Members", "url": "https://www.globenewswire.com/news-release/2023/06/13/2687120/0/en/Longeveron-Welcomes-Three-New-Prominent-Board-Members.html", "time_published": "20230613T123000", "authors": ["Longeveron"], "summary": "Seasoned Biotechnology and Corporate Management Experts, Khoso Baluch, Jeffrey Pfeffer, and Wa'el Hashad, Elected to Board at Annual Meeting of Stockholders ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/a6d6e61c-2a7d-4b22-954b-04b9841fbc38", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.140435, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LGVN", "relevance_score": "0.281584", "ticker_sentiment_score": "0.124943", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMD", "relevance_score": "0.028764", "ticker_sentiment_score": "0.008242", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.05749", "ticker_sentiment_score": "0.008996", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMGN", "relevance_score": "0.028764", "ticker_sentiment_score": "-0.024573", "ticker_sentiment_label": "Neutral"}, {"ticker": "UCBJF", "relevance_score": "0.028764", "ticker_sentiment_score": "0.008242", "ticker_sentiment_label": "Neutral"}]}, {"title": "Over $1M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying - Grove Collaborative Hldgs  ( NYSE:GROV ) , Processa Pharma  ( NASDAQ:PCSA ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/06/32832117/over-1m-bet-on-this-tech-stock-check-out-these-3-penny-stocks-insiders-are-aggressively-", "time_published": "20230613T113419", "authors": ["Lisa Levin"], "summary": "The Dow Jones closed higher by around 190 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/13/image39.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.249216, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SOL", "relevance_score": "0.520773", "ticker_sentiment_score": "0.347672", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.112532", "ticker_sentiment_score": "-0.246438", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GROV", "relevance_score": "0.520773", "ticker_sentiment_score": "0.311781", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCSA", "relevance_score": "0.428632", "ticker_sentiment_score": "0.411598", "ticker_sentiment_label": "Bullish"}]}, {"title": "Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress", "url": "https://www.globenewswire.com/news-release/2023/05/22/2673319/0/en/Processa-Pharmaceuticals-to-Participate-in-a-Panel-on-Interaction-with-the-FDA-at-the-World-Orphan-Drug-Congress.html", "time_published": "20230522T120500", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "Company also to provide a corporate overview in a separate session ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.230926, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.242285", "ticker_sentiment_score": "0.003787", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present PCS12852 Gastroparesis Results at the Digestive Disease Week 2023 Annual Meeting", "url": "https://www.globenewswire.com/news-release/2023/04/28/2657401/0/en/Processa-Pharmaceuticals-to-Present-PCS12852-Gastroparesis-Results-at-the-Digestive-Disease-Week-2023-Annual-Meeting.html", "time_published": "20230428T121500", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, April 28, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.231637, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.209365", "ticker_sentiment_score": "0.042133", "ticker_sentiment_label": "Neutral"}]}, {"title": "PCSA: Why Insiders Are Aggressively Buying This Under $1 Stock", "url": "https://stocknews.com/news/pcsa-gild-otsky-alxn-why-insiders-are-aggressively-buying-this-under-1-stock/", "time_published": "20230418T190914", "authors": [], "summary": "Insider buying activity for Processa Pharmaceuticals, Inc. ( PCSA ) indicates confidence in the company's growth prospects. Insiders have been net buyers of 5.4% shares of the company over the past six months.", "banner_image": "https://stocknews.com/wp-content/uploads/2023/01/ISt_Biotechnology.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.193744, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.784902", "ticker_sentiment_score": "0.323802", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GILD", "relevance_score": "0.195814", "ticker_sentiment_score": "0.193092", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying - Chembio Diagnostics  ( NASDAQ:CEMI ) , Malachite Innovations  ( OTC:MLCT ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/04/31805407/chembio-diagnostics-and-2-other-stocks-under-1-insiders-are-aggressively-buying", "time_published": "20230414T124906", "authors": ["Lisa Levin"], "summary": "The Dow Jones closed higher by around 380 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/14/chembio_diagnostics_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.303243, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MLCT", "relevance_score": "0.572601", "ticker_sentiment_score": "0.529613", "ticker_sentiment_label": "Bullish"}, {"ticker": "PCSA", "relevance_score": "0.572601", "ticker_sentiment_score": "0.40076", "ticker_sentiment_label": "Bullish"}, {"ticker": "CEMI", "relevance_score": "0.572601", "ticker_sentiment_score": "0.434636", "ticker_sentiment_label": "Bullish"}]}, {"title": "Processa Pharmaceuticals Announces First Patient Dosed in the 300 mg Dose Group with Next Generation Chemotherapy-Capecitabine", "url": "https://www.globenewswire.com/news-release/2023/03/17/2629471/0/en/Processa-Pharmaceuticals-Announces-First-Patient-Dosed-in-the-300-mg-Dose-Group-with-Next-Generation-Chemotherapy-Capecitabine.html", "time_published": "20230317T123000", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, March 17, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a developer of Next Generation Chemotherapies ( NGCs ) , today announced that the Company has dosed the first patient in its NGC-Capecitabine ( combination of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.180101, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.192183", "ticker_sentiment_score": "0.084553", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/03/07/2622067/0/en/Processa-Pharmaceuticals-to-Present-at-the-Oppenheimer-33rd-Annual-Healthcare-Conference.html", "time_published": "20230307T133000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, March 07, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , the developer of the Next Generation Chemotherapy drugs that will provide a better safety-efficacy profile than their widely used FDA-approved counterparts, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.208919, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.321673", "ticker_sentiment_score": "0.081009", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules", "url": "https://www.globenewswire.com/news-release/2023/02/10/2605900/0/en/Processa-Pharmaceuticals-Inc-Announces-6-25-Million-Registered-Direct-Offering-Priced-at-the-Market-Under-Nasdaq-Rules.html", "time_published": "20230210T130000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD., Feb. 10, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a diversified clinical-stage company developing next generation chemotherapy drugs for patients who have unmet medical conditions and/or require better treatment ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.928769"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.201818, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KO", "relevance_score": "0.061315", "ticker_sentiment_score": "0.127025", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.182506", "ticker_sentiment_score": "0.121106", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals To Present an Update on Its Future Therapeutic Focus and Strategy at the Biotech Showcase on January 11, 2023.", "url": "https://www.globenewswire.com/news-release/2023/01/04/2582922/0/en/Processa-Pharmaceuticals-To-Present-an-Update-on-Its-Future-Therapeutic-Focus-and-Strategy-at-the-Biotech-Showcase-on-January-11-2023.html", "time_published": "20230104T133000", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, Jan. 04, 2023 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) , Dr. David Young, Processa Pharmaceuticals, CEO will present an update on Processa's future therapeutic focus and strategy at the upcoming Biotech Showcase on January 11, 2023, at 10 am.", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.007123, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.434142", "ticker_sentiment_score": "-0.011577", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharma's Investigational Candidate Improves Gastroparesis-Associated Clinical Symptoms - Processa Pharma  ( NASDAQ:PCSA ) ", "url": "https://www.benzinga.com/general/biotech/22/12/30077697/processa-pharmas-investigational-candidate-improves-gastroparesis-associated-clinical-symptoms", "time_published": "20221214T180510", "authors": ["Vandana Singh"], "summary": "Processa Pharmaceuticals Inc PCSA announced topline results on the clinical symptoms associated with gastroparesis ( partial paralysis of the stomach ) from the Phase 2A study of PCS12852. The trial was designed to evaluate two dosage regimens of PCS12852 vs. placebo.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/12/14/image_resized.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.078254, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.498188", "ticker_sentiment_score": "0.015832", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial", "url": "https://www.globenewswire.com/news-release/2022/12/14/2573681/0/en/Processa-Pharmaceuticals-Announces-PCS12852-Successfully-Improves-the-Clinical-Symptoms-Associated-with-Gastroparesis-in-Phase-2A-Trial.html", "time_published": "20221214T133000", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, Dec. 14, 2022 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) , a diversified clinical-stage company developing products to improve survival and/or the quality of life for patients who have an unmet medical need condition, today announced positive top-line ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.029185, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.089797", "ticker_sentiment_score": "0.063043", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2022 Results and Provide Drug Development Update on November 8, 2022 at 4:30 p.m. EST", "url": "https://www.globenewswire.com/news-release/2022/11/02/2546524/0/en/Processa-Pharmaceuticals-to-Host-Conference-Call-to-Discuss-Third-Quarter-2022-Results-and-Provide-Drug-Development-Update-on-November-8-2022-at-4-30-p-m-EST.html", "time_published": "20221102T123000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Nov. 02, 2022 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) , a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need condition announces today it will host a ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.089749, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.369685", "ticker_sentiment_score": "0.041244", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Provides Update on Enrollment Across all Clinical Programs", "url": "https://www.globenewswire.com/news-release/2022/09/15/2516896/0/en/Processa-Pharmaceuticals-Provides-Update-on-Enrollment-Across-all-Clinical-Programs.html", "time_published": "20220915T123000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Sept. 15, 2022 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) , ( \"Processa\" or \"Company\" ) , a clinical stage biopharmaceutical company focused on developing products to improve survival and/or quality of life for patients who have an unmet medical need ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.09153, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.099752", "ticker_sentiment_score": "0.020594", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 12-14, 2022", "url": "https://www.globenewswire.com/news-release/2022/09/07/2511531/0/en/Processa-Pharmaceuticals-to-Present-at-H-C-Wainwright-22nd-Annual-Global-Investment-Conference-on-September-12-14-2022.html", "time_published": "20220907T123000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Sept. 07, 2022 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) , a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need condition today announced that Dr. Dr. ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.052417, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.362505", "ticker_sentiment_score": "0.040705", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Appoints Khoso Baluch and James Neal to its Board of Directors and Justin Yorke to Chairman of the Board", "url": "https://www.globenewswire.com/news-release/2022/08/16/2499067/0/en/Processa-Pharmaceuticals-Appoints-Khoso-Baluch-and-James-Neal-to-its-Board-of-Directors-and-Justin-Yorke-to-Chairman-of-the-Board.html", "time_published": "20220816T123000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "Board Appointments Designed to Position Company for Anticipated Milestones While Ensuring Adherence to the Highest Governance Standards ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.128658, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "XOMA", "relevance_score": "0.09347", "ticker_sentiment_score": "0.028254", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.139804", "ticker_sentiment_score": "0.041049", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMD", "relevance_score": "0.046816", "ticker_sentiment_score": "0.009858", "ticker_sentiment_label": "Neutral"}, {"ticker": "INCY", "relevance_score": "0.046816", "ticker_sentiment_score": "0.026632", "ticker_sentiment_label": "Neutral"}, {"ticker": "UCBJF", "relevance_score": "0.046816", "ticker_sentiment_score": "0.009858", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.046816", "ticker_sentiment_score": "0.026632", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.046816", "ticker_sentiment_score": "0.026632", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Host Conference Call to Discuss Its Second Quarter 2022 Results and Provide 2nd Half Clinical Pipeline Update on August 11, 2022, at 4:30 p.m. EST", "url": "https://www.globenewswire.com/news-release/2022/08/05/2493407/0/en/Processa-Pharmaceuticals-to-Host-Conference-Call-to-Discuss-Its-Second-Quarter-2022-Results-and-Provide-2nd-Half-Clinical-Pipeline-Update-on-August-11-2022-at-4-30-p-m-EST.html", "time_published": "20220805T190000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Aug. 05, 2022 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) , a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need condition announces today it will host a ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.054769, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.369685", "ticker_sentiment_score": "0.041244", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Announces Launch of Website to Increase Awareness of Ulcerative Necrobiosis Lipoidica and to Inform Patients of the ongoing Phase 2B Study of PCS499", "url": "https://www.globenewswire.com/news-release/2022/08/04/2492535/0/en/Processa-Pharmaceuticals-Announces-Launch-of-Website-to-Increase-Awareness-of-Ulcerative-Necrobiosis-Lipoidica-and-to-Inform-Patients-of-the-ongoing-Phase-2B-Study-of-PCS499.html", "time_published": "20220804T133000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, Aug. 04, 2022 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( NASDAQ: PCSA ) , ( \"Processa\" or the \"Company\" ) , a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical need conditions, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.012079, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.252332", "ticker_sentiment_score": "0.096601", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals to Present at the World Orphan Drug Congress USA, July 11-13, 2022", "url": "https://www.globenewswire.com/news-release/2022/07/12/2478070/0/en/Processa-Pharmaceuticals-to-Present-at-the-World-Orphan-Drug-Congress-USA-July-11-13-2022.html", "time_published": "20220712T123000", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD., July 12, 2022 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical stage biopharmaceutical company developing drugs to improve the survival and/or quality of life for patients who have unmet medical conditions announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.014479, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.178021", "ticker_sentiment_score": "0.030743", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update", "url": "https://www.globenewswire.com/news-release/2022/05/12/2442527/0/en/Processa-Pharmaceuticals-Announces-First-Quarter-2022-Financial-Results-and-Provides-Corporate-Update.html", "time_published": "20220512T202000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, Md., May 12, 2022 ( GLOBE NEWSWIRE ) -- Processa Pharmaceuticals, Inc. ( Nasdaq: PCSA ) ( \"Processa\" or the \"Company\" ) , a clinical stage company developing drugs for patients who have unmet medical conditions that require better treatment options to improve a patient's survival and", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.02509, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.154257", "ticker_sentiment_score": "-0.007273", "ticker_sentiment_label": "Neutral"}]}, {"title": "99 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/05/27156577/99-biggest-movers-from-yesterday", "time_published": "20220512T082956", "authors": ["Lisa Levin"], "summary": "Gainers Armstrong Flooring, Inc. ( NYSE: AFI ) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company. Regulus Therapeutics Inc. ( NASDAQ: RGLS ) surged 54.8% to close at $0.2660 after the company announ", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/12/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.066476, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BRP", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.007792", "ticker_sentiment_label": "Neutral"}, {"ticker": "STG", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.001401", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTRS", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.776356", "ticker_sentiment_label": "Bearish"}, {"ticker": "APEI", "relevance_score": "0.042462", "ticker_sentiment_score": "0.000919", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELBM", "relevance_score": "0.042462", "ticker_sentiment_score": "0.012571", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSE", "relevance_score": "0.042462", "ticker_sentiment_score": "0.056801", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIXT", "relevance_score": "0.042462", "ticker_sentiment_score": "0.000983", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERU", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.00097", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.033722", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.063655", "ticker_sentiment_score": "0.019119", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDUP", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.003071", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORGO", "relevance_score": "0.042462", "ticker_sentiment_score": "0.006482", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.063655", "ticker_sentiment_score": "0.001809", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.042462", "ticker_sentiment_score": "0.006677", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERB", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.000437", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.015448", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.042462", "ticker_sentiment_score": "0.007536", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLI", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.002424", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.024328", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELH", "relevance_score": "0.042462", "ticker_sentiment_score": "0.07644", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEN", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.014707", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPNT", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.049852", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.044697", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.042462", "ticker_sentiment_score": "0.002959", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIVE", "relevance_score": "0.063655", "ticker_sentiment_score": "0.002269", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYX", "relevance_score": "0.042462", "ticker_sentiment_score": "0.002559", "ticker_sentiment_label": "Neutral"}, {"ticker": "BORR", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.007181", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.704982", "ticker_sentiment_label": "Bearish"}, {"ticker": "WFC", "relevance_score": "0.021239", "ticker_sentiment_score": "0.006403", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFMS", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.174865", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RGLS", "relevance_score": "0.042462", "ticker_sentiment_score": "0.005123", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQ", "relevance_score": "0.021239", "ticker_sentiment_score": "0.050338", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKNO", "relevance_score": "0.063655", "ticker_sentiment_score": "0.004756", "ticker_sentiment_label": "Neutral"}, {"ticker": "STIM", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.107675", "ticker_sentiment_label": "Neutral"}, {"ticker": "VACC", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.000484", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBRG-P-I", "relevance_score": "0.021239", "ticker_sentiment_score": "0.006028", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDW", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.001274", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYMD", "relevance_score": "0.042462", "ticker_sentiment_score": "0.002008", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMGI", "relevance_score": "0.042462", "ticker_sentiment_score": "0.001246", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITOS", "relevance_score": "0.042462", "ticker_sentiment_score": "-1.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.021239", "ticker_sentiment_score": "0.148796", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCTK", "relevance_score": "0.042462", "ticker_sentiment_score": "0.00225", "ticker_sentiment_label": "Neutral"}, {"ticker": "VATE", "relevance_score": "0.063655", "ticker_sentiment_score": "0.000607", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRB", "relevance_score": "0.042462", "ticker_sentiment_score": "0.050338", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSTR", "relevance_score": "0.042462", "ticker_sentiment_score": "0.007596", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICHR", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.773707", "ticker_sentiment_label": "Bearish"}, {"ticker": "SMFL", "relevance_score": "0.042462", "ticker_sentiment_score": "0.0372", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVAX", "relevance_score": "0.042462", "ticker_sentiment_score": "0.000382", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISA", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.037892", "ticker_sentiment_label": "Neutral"}, {"ticker": "DM", "relevance_score": "0.063655", "ticker_sentiment_score": "0.007285", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.012145", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIEW", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.078713", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.375083", "ticker_sentiment_label": "Bearish"}, {"ticker": "TRVN", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.169005", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRGE", "relevance_score": "0.042462", "ticker_sentiment_score": "0.007344", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELY", "relevance_score": "0.042462", "ticker_sentiment_score": "0.012977", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNGR", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.012708", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRSYF", "relevance_score": "0.021239", "ticker_sentiment_score": "-0.107675", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.053584", "ticker_sentiment_label": "Neutral"}, {"ticker": "EA", "relevance_score": "0.042462", "ticker_sentiment_score": "0.003479", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.063655", "ticker_sentiment_score": "0.01422", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.017103", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.02247", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCUS", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.003576", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRTS", "relevance_score": "0.042462", "ticker_sentiment_score": "0.004184", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMD", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.002009", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.042462", "ticker_sentiment_score": "0.004038", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOEV", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.010579", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.042462", "ticker_sentiment_score": "0.002928", "ticker_sentiment_label": "Neutral"}, {"ticker": "TREC", "relevance_score": "0.042462", "ticker_sentiment_score": "0.003375", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.063655", "ticker_sentiment_score": "0.148796", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGS", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.545213", "ticker_sentiment_label": "Bearish"}, {"ticker": "GHRS", "relevance_score": "0.042462", "ticker_sentiment_score": "0.000566", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.010712", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFI", "relevance_score": "0.042462", "ticker_sentiment_score": "0.001813", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.021239", "ticker_sentiment_score": "-0.111561", "ticker_sentiment_label": "Neutral"}, {"ticker": "KODK", "relevance_score": "0.042462", "ticker_sentiment_score": "0.001583", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.698075", "ticker_sentiment_label": "Bearish"}, {"ticker": "EMBK", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.02072", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.037293", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.042462", "ticker_sentiment_score": "0.006403", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASS", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.134959", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRWG", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.433506", "ticker_sentiment_label": "Bearish"}, {"ticker": "NVAX", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.590938", "ticker_sentiment_label": "Bearish"}, {"ticker": "LMFA", "relevance_score": "0.042462", "ticker_sentiment_score": "0.002011", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.042462", "ticker_sentiment_score": "0.003784", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSM", "relevance_score": "0.042462", "ticker_sentiment_score": "0.103897", "ticker_sentiment_label": "Neutral"}, {"ticker": "XCUR", "relevance_score": "0.042462", "ticker_sentiment_score": "0.00228", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.063655", "ticker_sentiment_score": "-0.111561", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSGM", "relevance_score": "0.042462", "ticker_sentiment_score": "0.004124", "ticker_sentiment_label": "Neutral"}, {"ticker": "GO", "relevance_score": "0.042462", "ticker_sentiment_score": "0.024902", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMS", "relevance_score": "0.042462", "ticker_sentiment_score": "0.002684", "ticker_sentiment_label": "Neutral"}, {"ticker": "USER", "relevance_score": "0.042462", "ticker_sentiment_score": "0.000222", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWCH", "relevance_score": "0.042462", "ticker_sentiment_score": "0.006028", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIGL", "relevance_score": "0.042462", "ticker_sentiment_score": "0.003552", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRA", "relevance_score": "0.042462", "ticker_sentiment_score": "0.000238", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATLC", "relevance_score": "0.042462", "ticker_sentiment_score": "5.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLVM", "relevance_score": "0.042462", "ticker_sentiment_score": "0.002997", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXK", "relevance_score": "0.042462", "ticker_sentiment_score": "0.027782", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANPC", "relevance_score": "0.042462", "ticker_sentiment_score": "0.024528", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGR", "relevance_score": "0.042462", "ticker_sentiment_score": "-0.05841", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.021239", "ticker_sentiment_score": "0.007596", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.021239", "ticker_sentiment_score": "0.007596", "ticker_sentiment_label": "Neutral"}]}, {"title": "90 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/05/27100105/90-biggest-movers-from-yesterday", "time_published": "20220510T091132", "authors": ["Lisa Levin"], "summary": "Gainers\nHemisphere Media Group, Inc  ( NASDAQ: HMTV )  shares climbed 78.8% to close at $6.74 on Monday after the company announced it entered into a definitive agreement to be acquired for $7.00 per share in cash by a subsidiary of Gato Investments, a portfolio investment of Searchlight Capital Par", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/10/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.993856"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.025764, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSTR", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000102", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.050306", "ticker_sentiment_score": "-9.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PT", "relevance_score": "0.050306", "ticker_sentiment_score": "0.002554", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKTW", "relevance_score": "0.075397", "ticker_sentiment_score": "0.000774", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOTS", "relevance_score": "0.050306", "ticker_sentiment_score": "0.002375", "ticker_sentiment_label": "Neutral"}, {"ticker": "JOUT", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.825817", "ticker_sentiment_label": "Bearish"}, {"ticker": "MTP", "relevance_score": "0.050306", "ticker_sentiment_score": "-8.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNXC", "relevance_score": "0.025166", "ticker_sentiment_score": "0.011942", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGMCF", "relevance_score": "0.025166", "ticker_sentiment_score": "0.001764", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000296", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001362", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.050306", "ticker_sentiment_score": "0.002957", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYPS", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000496", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.075397", "ticker_sentiment_score": "0.006988", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.000564", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAT", "relevance_score": "0.075397", "ticker_sentiment_score": "-0.000822", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTE", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001612", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRGE", "relevance_score": "0.075397", "ticker_sentiment_score": "0.018933", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENO", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.000333", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRGV", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.072987", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNP", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.006795", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.050306", "ticker_sentiment_score": "0.014081", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001359", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZENV", "relevance_score": "0.075397", "ticker_sentiment_score": "0.00308", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.075397", "ticker_sentiment_score": "0.004012", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001346", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.050306", "ticker_sentiment_score": "0.014644", "ticker_sentiment_label": "Neutral"}, {"ticker": "EKSO", "relevance_score": "0.075397", "ticker_sentiment_score": "-0.00128", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTY", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.607113", "ticker_sentiment_label": "Bearish"}, {"ticker": "ARBK", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.003018", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000559", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.025166", "ticker_sentiment_score": "-0.006356", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEG", "relevance_score": "0.075397", "ticker_sentiment_score": "0.089525", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.050306", "ticker_sentiment_score": "0.005213", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBLG", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.000134", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.075397", "ticker_sentiment_score": "0.07667", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIFR", "relevance_score": "0.050306", "ticker_sentiment_score": "0.007084", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.050306", "ticker_sentiment_score": "0.002829", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOI", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000774", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAN", "relevance_score": "0.025166", "ticker_sentiment_score": "-0.005718", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001591", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCOM", "relevance_score": "0.050306", "ticker_sentiment_score": "0.002501", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRBO", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000219", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNWK", "relevance_score": "0.050306", "ticker_sentiment_score": "0.007185", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAR", "relevance_score": "0.050306", "ticker_sentiment_score": "0.002161", "ticker_sentiment_label": "Neutral"}, {"ticker": "EEX", "relevance_score": "0.050306", "ticker_sentiment_score": "0.003012", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGC", "relevance_score": "0.050306", "ticker_sentiment_score": "0.017519", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001333", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVR", "relevance_score": "0.025166", "ticker_sentiment_score": "-0.000822", "ticker_sentiment_label": "Neutral"}, {"ticker": "TANH", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.010443", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.075397", "ticker_sentiment_score": "0.026896", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAR", "relevance_score": "0.050306", "ticker_sentiment_score": "0.002663", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFI", "relevance_score": "0.075397", "ticker_sentiment_score": "-0.01209", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000701", "ticker_sentiment_label": "Neutral"}, {"ticker": "F", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000296", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENR", "relevance_score": "0.050306", "ticker_sentiment_score": "0.071073", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001552", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTTX", "relevance_score": "0.075397", "ticker_sentiment_score": "0.08825", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.050306", "ticker_sentiment_score": "0.004668", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.025166", "ticker_sentiment_score": "-0.050299", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPSIP", "relevance_score": "0.025166", "ticker_sentiment_score": "-0.001987", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVVE", "relevance_score": "0.075397", "ticker_sentiment_score": "-0.001108", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOUN", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001912", "ticker_sentiment_label": "Neutral"}, {"ticker": "SG", "relevance_score": "0.075397", "ticker_sentiment_score": "-0.039911", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEER", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.028162", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGHI", "relevance_score": "0.050306", "ticker_sentiment_score": "0.002044", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLPH", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001773", "ticker_sentiment_label": "Neutral"}, {"ticker": "THS", "relevance_score": "0.050306", "ticker_sentiment_score": "0.003181", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYRA", "relevance_score": "0.075397", "ticker_sentiment_score": "0.001089", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLTR", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.011178", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTV", "relevance_score": "0.050306", "ticker_sentiment_score": "0.004695", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.075397", "ticker_sentiment_score": "-0.006356", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISUN", "relevance_score": "0.050306", "ticker_sentiment_score": "0.003268", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNHC", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001655", "ticker_sentiment_label": "Neutral"}, {"ticker": "LWLG", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001908", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMTV", "relevance_score": "0.050306", "ticker_sentiment_score": "0.005277", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLVX", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.000618", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMS", "relevance_score": "0.050306", "ticker_sentiment_score": "0.011519", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.050306", "ticker_sentiment_score": "0.006565", "ticker_sentiment_label": "Neutral"}, {"ticker": "APTX", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000848", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIBT", "relevance_score": "0.050306", "ticker_sentiment_score": "0.001445", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYPR", "relevance_score": "0.050306", "ticker_sentiment_score": "0.040713", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRA", "relevance_score": "0.075397", "ticker_sentiment_score": "0.002676", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCTK", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.027824", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000529", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELU", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.003431", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOTUY", "relevance_score": "0.025166", "ticker_sentiment_score": "0.002375", "ticker_sentiment_label": "Neutral"}, {"ticker": "SREV", "relevance_score": "0.050306", "ticker_sentiment_score": "0.011942", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.050306", "ticker_sentiment_score": "0.000144", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.002553", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAOS", "relevance_score": "0.050306", "ticker_sentiment_score": "0.015945", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNON", "relevance_score": "0.050306", "ticker_sentiment_score": "0.00412", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:RON", "relevance_score": "0.025166", "ticker_sentiment_score": "-0.011067", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.001558", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.050306", "ticker_sentiment_score": "-0.001558", "ticker_sentiment_label": "Neutral"}]}, {"title": "90 Biggest Movers From Yesterday", "url": "https://markets.businessinsider.com/news/stocks/90-biggest-movers-from-yesterday-1031440764", "time_published": "20220510T091132", "authors": [], "summary": "Hemisphere Media Group, Inc  (  NASDAQ:HMTV  )  shares climbed 78.8% to close at $6.74 on Monday after the company announced it entered into a definitive agreement to be acquired for $7.00 per share in cash by a subsidiary of Gato Investments, a portfolio investment of Searchlight Capital Partners.", "banner_image": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2022/05/10/yesterdays_movers.png", "source": "Business Insider", "category_within_source": "n/a", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.993856"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.019866, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSTR", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000702", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001118", "ticker_sentiment_label": "Neutral"}, {"ticker": "PT", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001502", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKTW", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000111", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOTS", "relevance_score": "0.023017", "ticker_sentiment_score": "0.002842", "ticker_sentiment_label": "Neutral"}, {"ticker": "JOUT", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.643048", "ticker_sentiment_label": "Bearish"}, {"ticker": "MTP", "relevance_score": "0.023017", "ticker_sentiment_score": "0.00036", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNXC", "relevance_score": "0.023017", "ticker_sentiment_score": "0.00757", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGMCF", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001635", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000624", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001632", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.023017", "ticker_sentiment_score": "0.002452", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYPS", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001993", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.046015", "ticker_sentiment_score": "0.002684", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000581", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAT", "relevance_score": "0.046015", "ticker_sentiment_score": "-0.001864", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTE", "relevance_score": "0.023017", "ticker_sentiment_score": "0.002364", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRGE", "relevance_score": "0.046015", "ticker_sentiment_score": "0.007578", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENO", "relevance_score": "0.023017", "ticker_sentiment_score": "5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRGV", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.025779", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNP", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.001487", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.023017", "ticker_sentiment_score": "0.029655", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000922", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZENV", "relevance_score": "0.046015", "ticker_sentiment_score": "0.002156", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.046015", "ticker_sentiment_score": "0.001265", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000783", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.023017", "ticker_sentiment_score": "0.002786", "ticker_sentiment_label": "Neutral"}, {"ticker": "EKSO", "relevance_score": "0.046015", "ticker_sentiment_score": "-0.000409", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTY", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.462422", "ticker_sentiment_label": "Bearish"}, {"ticker": "ARBK", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.000867", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.023017", "ticker_sentiment_score": "0.00185", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.023017", "ticker_sentiment_score": "0.002889", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEG", "relevance_score": "0.046015", "ticker_sentiment_score": "0.039951", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.023017", "ticker_sentiment_score": "0.004335", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBLG", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000175", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.046015", "ticker_sentiment_score": "0.023388", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIFR", "relevance_score": "0.023017", "ticker_sentiment_score": "0.004736", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.000365", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOI", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000499", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAN", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.000479", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.023017", "ticker_sentiment_score": "0.003484", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCOM", "relevance_score": "0.023017", "ticker_sentiment_score": "0.002483", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRBO", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000283", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNWK", "relevance_score": "0.023017", "ticker_sentiment_score": "0.004858", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAR", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000551", "ticker_sentiment_label": "Neutral"}, {"ticker": "EEX", "relevance_score": "0.023017", "ticker_sentiment_score": "0.002778", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGC", "relevance_score": "0.023017", "ticker_sentiment_score": "0.012186", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001618", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVR", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.001864", "ticker_sentiment_label": "Neutral"}, {"ticker": "TANH", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.005783", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.046015", "ticker_sentiment_score": "0.00863", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAR", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000934", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFI", "relevance_score": "0.046015", "ticker_sentiment_score": "-0.004395", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.023017", "ticker_sentiment_score": "4.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "F", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000624", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENR", "relevance_score": "0.023017", "ticker_sentiment_score": "0.021523", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001132", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTTX", "relevance_score": "0.046015", "ticker_sentiment_score": "0.054016", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.023017", "ticker_sentiment_score": "0.003321", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.023198", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPSIP", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.001059", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVVE", "relevance_score": "0.046015", "ticker_sentiment_score": "-0.001502", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOUN", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001195", "ticker_sentiment_label": "Neutral"}, {"ticker": "SG", "relevance_score": "0.046015", "ticker_sentiment_score": "-0.030193", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEER", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.008046", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGHI", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000679", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLPH", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001063", "ticker_sentiment_label": "Neutral"}, {"ticker": "THS", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001495", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYRA", "relevance_score": "0.046015", "ticker_sentiment_score": "0.001044", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLTR", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.003014", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTV", "relevance_score": "0.023017", "ticker_sentiment_score": "0.002175", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.046015", "ticker_sentiment_score": "0.002889", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISUN", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000706", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNHC", "relevance_score": "0.023017", "ticker_sentiment_score": "0.003387", "ticker_sentiment_label": "Neutral"}, {"ticker": "LWLG", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001326", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMTV", "relevance_score": "0.023017", "ticker_sentiment_score": "0.004107", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLVX", "relevance_score": "0.023017", "ticker_sentiment_score": "-9.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMS", "relevance_score": "0.023017", "ticker_sentiment_score": "0.006433", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.023017", "ticker_sentiment_score": "0.00216", "ticker_sentiment_label": "Neutral"}, {"ticker": "APTX", "relevance_score": "0.023017", "ticker_sentiment_score": "0.00056", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIBT", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000738", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYPR", "relevance_score": "0.023017", "ticker_sentiment_score": "0.003183", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRA", "relevance_score": "0.046015", "ticker_sentiment_score": "0.002129", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCTK", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.036294", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000494", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELU", "relevance_score": "0.023017", "ticker_sentiment_score": "-0.000658", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOTUY", "relevance_score": "0.023017", "ticker_sentiment_score": "0.002842", "ticker_sentiment_label": "Neutral"}, {"ticker": "SREV", "relevance_score": "0.023017", "ticker_sentiment_score": "0.00757", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.023017", "ticker_sentiment_score": "0.000328", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.023017", "ticker_sentiment_score": "0.001046", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAOS", "relevance_score": "0.023017", "ticker_sentiment_score": "0.009942", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNON", "relevance_score": "0.023017", "ticker_sentiment_score": "0.002631", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.046015", "ticker_sentiment_score": "0.000813", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.046015", "ticker_sentiment_score": "0.000813", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Doses First Patient in Amended Phase 1B Protocol for PCS6422 Combined with Capecitabine  ( Next Generation Capecitabine ) ", "url": "https://www.globenewswire.com/news-release/2022/04/20/2425479/0/en/Processa-Pharmaceuticals-Doses-First-Patient-in-Amended-Phase-1B-Protocol-for-PCS6422-Combined-with-Capecitabine-Next-Generation-Capecitabine.html", "time_published": "20220420T123000", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "Processa focuses on identifying the PCS6422 regimens to increase capecitabine potency while identifying the MTD of Next Generation Capecitabine", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.003003, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.131884", "ticker_sentiment_score": "-0.003003", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for the Treatment of Gastroparesis", "url": "https://www.globenewswire.com/news-release/2022/04/05/2416670/0/en/Processa-Pharmaceuticals-Announces-First-Patient-Enrolled-in-the-PCS12852-Phase-2A-Trial-for-the-Treatment-of-Gastroparesis.html", "time_published": "20220405T123000", "authors": ["Processa Pharmaceuticals", "Inc."], "summary": "HANOVER, MD, April  05, 2022   ( GLOBE NEWSWIRE )  -- Processa Pharmaceuticals, Inc.  ( NASDAQ: PCSA ) ,  ( \"Processa\" or the \"Company\" ) , a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need, annou", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.00427, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.092694", "ticker_sentiment_score": "0.00427", "ticker_sentiment_label": "Neutral"}]}, {"title": "Processa Pharmaceuticals To Host Conference Call to Discuss Fourth Quarter 2021 Results and Provide Drug Development Update on March 30 at 4:30 p.m. EST", "url": "https://www.globenewswire.com/news-release/2022/03/23/2408539/0/en/Processa-Pharmaceuticals-To-Host-Conference-Call-to-Discuss-Fourth-Quarter-2021-Results-and-Provide-Drug-Development-Update-on-March-30-at-4-30-p-m-EST.html", "time_published": "20220323T123000", "authors": ["Inc.", "Processa Pharmaceuticals"], "summary": "HANOVER, MD, March  23, 2022   ( GLOBE NEWSWIRE )  -- Processa Pharmaceuticals, Inc.  ( Nasdaq: PCSA ) , a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need condition announces today it will host a ", "banner_image": "https://ml.globenewswire.com/Resource/Download/b829db54-d8cd-4fd0-ac70-5db2a605d4de?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.014746, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PCSA", "relevance_score": "0.32478", "ticker_sentiment_score": "0.014746", "ticker_sentiment_label": "Neutral"}]}]}